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ABSTRACT 
Developing tools to elucidate the chemical distribution of lipid components within the 
eukaryotic cellular membrane is critical to understanding their role in many cell 
processes. Secondary ion mass spectrometry (SIMS) is a technique that offers both 
chemical and spatial specificity, and has become popularized over the last decade for 
analyzing model and native cellular membranes. Herein, this thesis describes the use 
and development of SIMS for such samples. By employing high-resolution SIMS, 
performed on a Cameca NanoSIMS 50, and atomic force microscopy (AFM) the 
influence of cholesterol on the phase behavior of supported lipid membranes containing 
saturated phosphatidylcholine lipid species was studied. While the NanoSIMS 50 
afforded unprecedented lateral resolution on the chemical distribution of these model 
membranes, it was achieved at the cost of employing stable-isotope labels for 
component identification. Time-of-flight SIMS (TOF-SIMS), on the other hand, is a 
molecular imaging technique that does not require the use of labeled species. However, 
the ability to image characteristic lipid fragments (i.e. lipid headgroups, etc.) at lateral 
resolutions comparable to the NanoSIMS 50 is challenging. Furthermore, many of the 
characteristic fragments are common between structurally similar lipids, such as 
different phosphatidylcholine species, making discrimination between these species 
difficult. This challenge was overcome by developing a multivariate analysis (MVA) 
method, called principal component analysis (PCA), for evaluating the TOF-SIMS 
spectra of these samples. As a result, the ability to image and identify saturated 
phosphatidylcholine lipids that differ only in chain length within phase-separated 
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membranes was achieved and could be registered to the corresponding AFM image. By 
performing PCA to compare TOF-SIMS spectra of labeled and unlabeled species, the 
molecular ion peaks that are associated with these phosphatidylcholine lipids were 
identified. These known ion peaks were then used to optimize PCA for TOF-SIMS 
imaging of phase-separated supported lipid membranes to attain a greater lateral 
characterization of these samples. The ability to gain quantitative information from TOF-
SIMS analysis of homogenous supported lipid membranes was made possible by 
performing partial least squares regression (PLSR) on the resulting mass spectrum. 
Here, calibration samples were modeled, and then used to quantitatively predict the 
content of unknown membrane samples. Lastly, a TOF-SIMS MVA approach was 
utilized to evaluate native cellular membranes with the goals of differentiating between 
cell types, and in a separate project, identify the binding of vascular endothelial growth 
factors to human endothelial cells. 
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Chapter 1.  
INTRODUCTION 
 
Cellular Membranes 
 The eukaryotic cellular membrane is a highly dynamic and complex structure. 
Classically, the membrane was thought to be a homogenous sea of lipids, where 
integral proteins could freely diffuse laterally across the membrane, and displayed no 
semblance of an ordered structure. However, mounting evidence over the last few 
decades has suggested that nonrandom distribution of components exists laterally 
across the cellular membrane.1-4 This has been proven conclusively for protein 
clustering in the plasma membrane, which can be observed using affinity labels (i.e. 
labeled antibodies) or fluorescent protein constructs.3,5 Lipid components, on the 
other hand, were not generally thought to be heterogeneously distributed across the 
membrane until rather recently, even though evidence as early as the 1970s 
suggested as such.4,6-10 Compositionally distinct cholesterol and sphingolipid-
enriched domains, known as ʻlipid rafts,ʼ are now believed to play vital roles in many 
cell functions, including signaling, transport, and sorting.11-17 
 Still unclear, however, are questions concerning the precise composition of 
lipid rafts within the cell membrane and the mechanism that drives lipid 
heterogeneity, whether it is lipid-protein and/or lipid-lipid (specifically lipid-cholesterol) 
interactions. This is in part due to the indirect methods with which these properties 
are assessed. For example, while detergent-resistance based extraction may point to 
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physiological relevant biases in lateral composition, and fluorescence microscopy 
methods may provide mechanistic information of protein and lipid transport across 
the membrane, these methods are commonly used without regard for the artifacts 
that can be generated in the native membrane by using these techniques.18-24 
Consequently, how cell membrane organization influences biological processes is 
still mostly unknown, likely due to a lack of suitable imaging methods. 
 
Model Membranes 
 Due to the complexity of natural cellular membranes, many different model 
systems have been created that retain the same lipid bilayer structure, yet simplify 
the membrane system. By employing model membranes, one is afforded the 
possibility of visualizing the organization and dynamics of individual components 
within the membrane, and can, consequently, investigate their roles within the 
membrane. There are many different models and approaches that have been 
developed and studied, as illustrated in Figure 1.1.25 Perhaps the two most 
commonly studied types of model membranes are giant unilamellar vesicles (GUVs) 
and supported lipid bilayers (SLBs), which are frequently used to characterize phase 
behavior of binary and ternary lipid mixtures. In particular, these models have been 
vital to investigations that probe the composition of heterogeneous lipid domains and 
in determining whether the mechanisms of lipid-lipid and/or lipid-cholesterol 
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interactions are sufficient to form lipid domains with analogous properties to cellular 
membrane lipids rafts.  
 
Figure 1.1. A collection of model lipid membrane systems surrounding a schematic diagram of a cell 
that emphasizes the large number of different membrane surfaces. Clockwise, beginning from the 
upper left: (a) giant unilamellar vesicles (GUVs) and blebs; (b) networks of giant vesicles connected by 
lipid microtubules; (c) ruptured GUV's on solid supported bilayers; (d) membrane nanodiscs containing 
transmembrane proteins; (e) supported lipid bilayers (SLBs) analyzed by NanoSIMS and AFM; (f) 
ruptured cell membranes on solid supports; (g) bilayers containing ion channels tethered to a solid 
support; (h) vesicles tethered to a SLB by DNA; (i) visual representation of multi-scale simulations. 
Figure reproduced with permission from Ref 25. 
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GUVs are generally created from well-defined combinations of pure lipids and 
cholesterol, are typically 1-10 µm in size, and have been of great value to 
understanding the phase behavior of lipid mixtures.23,24,26,27 The basic experimental 
technique for attaining phase information from these model membranes is 
fluorescence microscopy, where phase separation can be imaged (as seen in Figure 
1.1A) using fluorescent lipophilic dyes that selectively partition into the gel, liquid-
ordered (Lo), or liquid-disorder (Ld) phase.26 In general, these models can only be 
analyzed by a narrow range of analytical techniques, where fluorescence 
microscopy, as stated being the workhorse method, has some deficiencies of its own. 
These include a limited lateral resolution, the need for high intensity light sources that 
can cause artificial phase behavior, and that compositional information must be 
inferred.23, 28  
 Conversely, SLBs offer a planar configuration, which make them amendable to 
a greater variety of analytical approaches that include surface-sensitive techniques 
originally developed for material sciences, geochemistry, and catalysis.29-31 SLBs can 
be formed a number of ways, but bilayers formed by slow-cooled vesicle fusion are 
novel in that they exhibit similar phase behavior to that of free standing GUVs.32 
When bilayers are created by the vesicle fusion process, a few nanometers-thick 
layer of water is present separating the bilayer from the substrate, enabling the lipids 
to diffuse laterally within each leaflet analogous to a cell membrane.33 However, 
these bilayers are only stable in aqueous solutions, and will delaminate from the 
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support upon contact with air.33,34 Numerous studies have successfully demonstrated 
the viability of flash-freezing followed by freeze-drying the SLBs to remove the water 
layer, yielding the ability for in-air analyses.25,29,30,35 SLBs preserved in this fashion 
are referred to as supported lipid membranes. Once preserved, a supported lipid 
membrane can be analyzed by a number of surface characterization techniques in 
succession, providing complementary information about the membranes 
properties.29,36,37 Considering the advantages, phase-separated supported lipid 
membranes make an excellent model for determining chemical composition of lipid 
domains and simultaneously provide insight into lipid phase behavior. 
 
Common Characterization Techniques 
 Phase-separated SLBs have been studied by an array of methods, including 
fluorescence microscopy, atomic force microscopy (AFM), near-field scanning optical 
microscopy, X-ray photoelectron spectrometry, quartz crystal microbalance, surface 
plasmon resonance, and secondary ion mass spectrometry (SIMS).38-43 All of these 
methods possess their own advantages, and each provides a  unique insight into the 
properties of phase-separated lipid membranes. However, the discussion here will be 
limited to techniques most pertinent to this thesis, which are fluorescence 
microscopy, AFM, and SIMS. 
 Imaging phase separation within supported lipid membranes using 
fluorescence microscopy is commonly performed by adding a small amount of a 
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fluorescently labeled lipid to the lipid mixture, pre-bilayer formation.37,44 The labeled 
molecule will be selectively excluded from the more densely packed, ordered lipid 
phase (gel or Lo), thus the less densely packed, disordered phase (Ld) will appear 
bright under the fluorescence microscope. The fluorescence microscopy experiments 
reported in this thesis are diffraction limited, making nanometer-size features difficult 
to resolve. Regardless of this limitation, fluorescence microscopy is a valuable 
technique for rapidly evaluating sample quality, and can generate image mosaics of 
the entire sample that are used to relocate specific areas of the supported lipid 
membrane for characterization with additional techniques. 
Phase-separation in supported lipid membranes can also be imaged using 
AFM, by which topographical changes resulting from different membrane thicknesses 
are detected. Membrane thickness is directly attributed to variations in acyl chain 
packing, where the more densely packed gel-phase domains are thicker than Lo-
phase domains, which are thicker than the loosely packed Ld-phase domains. Thus, 
when measuring supported lipid membranes with the AFM, gel-phase domains will 
be the tallest and Ld-domains will be the shortest.45-47 AFM offers excellent lateral and 
height resolution of <2 nm and <0.1 nm, respectively, for supported lipid membranes, 
and similar to fluorescence microscopy, can be performed on hydrated SLBs or 
freeze-dried supported lipid membranes.39 While fluorescence microscopy and AFM 
provide dynamic and microstructural information about the membrane, respectively, 
composition must be inferred.  
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Figure 1.2. A general schematic of a secondary ion 
mass spectrometer (SIMS) instrument. A primary 
ion source bombards the surface of a sample 
creating secondary ions of the superficial molecules, 
which are removed via ion extraction optics, and 
sent to a mass spectrometer. The types of mass 
spectrometers include time-of-flight (TOF), magnetic 
sector, and quadrapoles. 
 
 
 
Secondary Ion Mass Spectrometry 
SIMS is a direct approach to composition analysis. Though largely 
underutilized for biological sample analysis, SIMS is positioned to be at the vanguard 
of membrane analysis because it has the potential to provide the location-specific 
compositional information on cell and model lipid membranes that is currently 
missing.29,38,48,49 In SIMS, an accelerated ion beam bombards the surface, sputtering 
superficial molecules and molecular fragments that are within the beamʼs focal area. 
The masses of the sputtered ionized species, called secondary ions, provide 
information about the composition of the sampleʼs surface (Figure 1.2). Time-of-flight 
SIMS (TOF-SIMS) is the most popular SIMS technique for analyzing biological 
membranes. In this approach, the pulsed ion beam produces molecular secondary 
ions, enabling a full mass spectrum to be recorded at each beam position using a 
TOF mass spectrometer (Figure 1.3).50 When using TOF-SIMS, the detection of 
molecular ions and high-mass molecular fragment ions, specific to the parent 
molecule, is desirable. By rastering the ion beam across the sample, an image 
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revealing the distribution of these distinctive ions, and thus the components that 
produced them, is created. The high chemical specificity, and its application to 
unlabeled species, renders TOF-SIMS a powerful method for analyzing the lateral 
composition of biological membranes.48,51,52 Unfortunately, characteristic secondary 
ions that permit unambiguous component identification commonly do not produce 
sufficient yields to enable composition imaging at submicron lateral resolution.38 
Typically, biological membrane analysis by TOF-SIMS has a lateral resolution of a 
micron, whereas lipid domains are expected to be submicron in size.53 
 
Figure 1.3. A general schematic of a time-of-flight SIMS (TOF-SIMS) instrument. TOF-SIMS is 
typically operated in static mode, where the primary ion source is pulsed generating molecular 
secondary ions that are detected based upon their mass-to-charge (m/z) with a TOF mass 
spectrometer. Figure taken from Ref 50 (open source). 
 
Alternatively, dynamic SIMS uses high yielding atomic and diatomic secondary 
ions for component identification. High lateral resolution (50 nm) has been attained 
for dynamic SIMS performed on the NanoSIMS 50 (Cameca; Figure 1.4).38 In this 
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configuration, a cesium or oxygen ion beam extensively fragments the molecules 
within the beamʼs focal area. Up to five or seven atomic and diatomic secondary ions 
with different mass-to-charge (m/z) ratios, depending on the instrument model, are 
detected in parallel by a magnetic sector mass spectrometer with high mass 
resolving power (i.e., 12C15N-, 26.9996 amu and 13C14N-, 27.0059 amu can be 
separated). The intensities of the preselected ions measured at each location are 
used to create maps of the sampleʼs elemental and isotopic distributions. In order to 
differentiate molecules with the same elemental composition, molecules of interest 
must be labeled with a distinct stable isotope so that the isotopically enriched atomic 
and diatomic secondary ions generated during analysis encode for component 
identity.  
Recently, the distributions of isotopically labeled lipids within phase-separated 
supported lipid membrane have been successfully imaged with 100 nm-lateral 
resolution by the NanoSIMS.30 The lipid-specific 13C1H- and 12C15N- secondary ions 
revealed the distributions of 13C-labeled 1,2-distearoylphosphatidylcholine (13C-
DSPC, gel phase) and 15N-labeled 1,2-dilauroylphosphatidylcholine (15N-DLPC, fluid 
phase), respectively (Figure 1.5A and B, respectively), in the membrane. Comparison 
of the NanoSIMS images to the AFM topographic data (Figure 1.5C and D) acquired 
at the same sample locations prior to the NanoSIMS analysis enabled determination 
of the lipid composition within specific structures that were detected by AFM. The 
lipid composition at small regions of the membrane could also be quantified by using 
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standard samples to calibrate the normalized lipid-specific secondary ion signal 
intensities.30,54 Consequently, the NanoSIMS is capable of providing compositional 
information on a length scale that is relevant to biological membrane organization, 
which complements the structural and dynamic information that can be acquired with 
AFM and fluorescence microscopy, respectively.  
 
Figure 1.4. Schematic of the NanoSIMS 50 (Cameca) illustrating the major components for imaging. 
Here, the SIMS is operated in the dynamic mode and the primary ion beam is constantly bombarding 
the surface, generating atomic and diatomic ions of the parent surface molecule. The co-axial optics 
enable co-propagation of the primary and secondary ions, thereby reducing the beam's focal area and 
enhancing secondary ion collection. Secondary ions are analyzed based upon their mass-to-charge 
(m/z) ratio in a magnetic sector mass spectrometer. 
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Figure 1.5. NanoSIMS analysis of a freeze-dried, phase-separated supported lipid membrane 
composed of 15N-1,2-dilauroylphosphatidylcholine (15N-DLPC) and 13C18-1,2-
distearoylphosphatidylcholine (13C18-DSPC) (A-C) and the atomic force microscopy (AFM) topography 
image of the same membrane location (D). (A) The normalized 12C15N− secondary ion signal intensity 
(green) reveals the distribution of 15N-DLPC in this area, and (B) the normalized 13C1H− secondary ion 
signal (red) shows the distribution of 13C18-DSPC in the membrane. (C) Overlay of the two lipid-specific 
ion signals.  
 
Principal Component Analysis 
 While the NanoSIMS is capable of achieving compositional information about 
model membranes at unprecedented lateral dimensions, label-free approaches are 
desirable for sample preparation and SIMS analysis of native cell membranes. TOF-
SIMS analysis of membranes, as discussed previously, does not require the use of 
labels, but the types of fragment ions used to discriminate between species generate 
insufficient ion yields to achieve submicron resolution.55,56 Low molecular weight 
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fragments ions, conversely, do produce ample yields to achieve submicron 
resolution, but are common to many parent species, which prohibits their use for 
identification. However, the extensive data sets generated by TOF-SIMS analysis, 
resulting from obtaining an entire mass spectrum of a surface, is especially suitable 
for incorporating the use of multivariate analysis (MVA) methods. 
Principal component analysis (PCA), a method of MVA, has been particularly 
useful in classifying and identifying many biomolecules based upon variances 
between TOF-SIMS spectra.57-60 PCA is capable of identifying parent molecules by 
using several mass fragments to distinguish the similarities and discrepancies in the 
TOF-SIMS data acquired from different samples.61,62 Briefly, in PCA the data 
complexity is reduced by calculating new variables, or principal components (PCs), 
which represent linear combinations of the original variables and capture the greatest 
variation in the data set.63 As a result, the abundant low mass ions, not utilized for 
univariate spectra interpretation, can be used for component identification based on 
the variance in relative ion yields.61 PCA can be applied to images as well, by 
unfolding the n number of ion images that are I by J pixels, and reshaping the data to 
form a single 2-D array matrix with n columns and I multiplied by J rows.55,64 PCA is 
then performed on the resulting matrix and scores are calculated for each pixel based 
upon how they correlate to a given PC. The data is reassembled into an image with I 
by J pixels in which the score value on each PC is encoded in a pseudo-color scale. 
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By applying PCA to TOF-SIMS images, an increase in image contrast and 
improvements in specificity for component identification can be achieved.61,62,65-67  
 
Scope and Aim of Thesis 
  This thesis describes the development of SIMS techniques for analyzing 
supported lipid membranes. The use of SIMS and multivariate analysis to 
discriminate cells according to variations in the chemical composition of the cell 
surface is also explored.  
In Chapter 2, high-resolution SIMS performed with a NanoSIMS instrument is 
extended to three-component lipid membranes. By coupling complementary 
information gained by using AFM and the NanoSIMS, the effect of cholesterol on 
phase separation was studied. This project endeavored to determine if cholesterol 
would induce lipid intermixing between the gel- and fluid-phase lipid components, and 
if cholesterol-lipid interactions were sufficient to form Lo-phase domains, which are 
thought to be analogous in phase to cellular lipid rafts.24,26  
 While implementing the NanoSIMS is one part of this thesis, the majority of 
this thesis focuses on the using TOF-SIMS. In Chapters 3 and 4, TOF-SIMS coupled 
with PCA was employed to discriminate saturated lipid species containing the same 
phosphocholine headgroup that differed only in the length of the hydrocarbon tails. 
PCA was then used on TOF-SIMS images of phase-separated lipid membranes to 
reveal domains of differing lipid composition (Chapter 3). By using PCA to 
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discriminate between isotope-labeled lipids and the analogous unlabeled (natural 
abundance) lipid, the lipid-related TOF-SIMS fragments could be identified (Chapter 
4). This a priori knowledge of the lipid-related fragments improved PCA discrimination 
between lipid species and verified that discrimination is a function of composition, as 
opposed to sample-specific contaminants. As a final project for developing this 
method for analysis of supported lipid membranes, another MVA technique called 
partial least squares regression (PLSR),68,69 was used to acquire quantitative 
information about the composition of homogenous supported membranes containing 
a lipid species and cholesterol (Chapter 5). This method could be used for quantifying 
lipids and cholesterol within distinct domains of phase-separated supported lipid 
membranes. Lastly, this thesis discusses work in progress to use TOF-SIMS and 
MVA to differentiate different cell types according to cellular membrane composition 
(Chapter 6). Here, different cellular types were discriminated and classified based 
upon the composition of their respective cellular membranes using PLS discriminate 
analysis (PLS-DA), and, in an unrelated study, PCA was used to determine cellular 
membrane differences between normal human endothelial cells and cells modified 
with a vascular endothelial growth factor. 
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Chapter 2.  
CORRELATED AFM AND NANOSIMS IMAGING TO PROBE 
CHOLESTEROL-INDUCED CHANGES IN PHASE BEHAVIOR 
AND NON-IDEAL MIXING IN TERNARY LIPID MEMBRANES 
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Introduction  
 Lateral variations in component distribution within the plasma membrane are 
required to coordinate membrane-mediated cellular functions.2-4 The nonrandom 
distributions of certain proteins within the plasma membrane are well-established.5-10 
Lipids and cholesterol are also believed to be spatially organized in biological 
membranes, but whether their organization is driven by lipid-lipid or lipid-protein 
interactions is not clear.2-4 In one model of plasma membrane organization, 
differential affinities between cholesterol and other membrane components are 
hypothesized to drive the formation of liquid-ordered, cholesterol- and sphingolipid-
enriched nanoscale domains (diameters < 300 nm) that are referred to as lipid 
rafts.2,3,11,12 Thus, characterizing the effects of cholesterol-dependent interactions on 
component distribution within the plasma membrane is the goal of much research.    
Insight into how lipid-cholesterol and lipid-lipid interactions might influence lipid 
organization within biological membranes has been acquired by studying model lipid 
membranes.13 In the absence of cholesterol, membranes composed of a low- and 
high-melting temperature lipid component homogeneously mix when heated above 
the melting transition temperature (Tm) of both lipid species, but separate into 
disordered fluid-phase and ordered gel-phase domains when cooled below the Tm of 
the high-melting temperature lipid species.14,15 The addition of cholesterol to the 
membrane affects the lipid miscibility and domain microstructure observed at room 
temperature in a manner that depends on the degree of saturation in the low-melting 
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temperature lipid.16-19 At low cholesterol concentrations, membranes composed of a 
di-unsaturated low Tm lipid, such as 1,2-dioleoyl-sn-glycero-3-phosphocholine 
(DOPC), and a high Tm lipid species exhibit macroscopic fluid- and gel-phase 
domains.14,19 At higher cholesterol concentrations (mole fraction > ~0.16), the gel-
phase is replaced by macroscopic liquid-ordered domains that coexist with the 
disordered fluid-phase.14,16,18,20-22 Above a threshold cholesterol concentration (mole 
fraction > ~0.4), phase separation ceases and homogeneous lipid mixing 
occurs.14,16,18,20-22 In contrast, macroscopic liquid-ordered domains are usually not 
detected in cholesterol-containing ternary membranes in which the lipid species with 
the low Tm is saturated, such as 1,2-dilauroyl-sn-glycero-3-phosphocholine 
(DLPC).14,16,18,19,23-26 The gel-phase domains that coexist with the disordered fluid-
phase undergo a reduction in size without the formation of macroscopic, liquid-
ordered domains as the cholesterol concentration increases.19,25,26 For example, 
Figure 2.1 shows the ternary phase diagram determined by Zhao et al. for giant 
unilamellar vesicles (GUVs) composed of DLPC/1,2-distearoyl-sn-glycero-3-
phosphocholine (DSPC)/cholesterol at room temperature.26 At a threshold cholesterol 
concentration (0.15 – 0.2 mole fraction), phase separation could not be visualized in 
GUVs using conventional fluorescence microscopy, but fluorescence resonance 
energy transfer (FRET) measurements indicate that the membrane is not 
homogeneously mixed.18,26 This FRET behavior is postulated to be due to the 
presence of nanoscopic liquid-ordered domains in the membrane, even though tiny 
23 
gel-phase domains and distinct lipid clusters transiently produced by non-ideal mixing 
may also be consistent with these results.18, 21, 23, 26, 27 
 
 
Figure 2.1. Ternary phase diagram for giant unilamellar vesicles composed of 
DLPC/DSPC/cholesterol at room temperature. Uniform fluorescence and phase separation was 
observed at compositions marked by “○” and “●”, respectively. Green crosses “X” mark the 
compositions of the vesicles used to form the supported lipid membranes that were characterized with 
AFM and NanoSIMS in this study (an equal molar ratio of DLPC/DSPC with 0, 3, 7, 15, and 19 mol% 
cholesterol). The molar concentration of cholesterol in each lipid mixtures used to make the supported 
lipid membranes was determined using commercially available enzymatic assays. Reprinted from Ref. 
26 with permission from Elsevier. Phase notation for liquid-ordered (Lo), gel (Lβ) phase and fluid (Lα) 
phase from Gosku and Longo (Ref. 28) have been added.  
 
Although saturated, low Tm lipids are rarely found in cellular membranes, 
identification of how this change in lipid structure alters membrane phase behavior 
provides a better understanding of the physiological significance of fatty acid chain 
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unsaturation in biological membranes. Moreover, demonstration of the existence of 
nanoscopic liquid-ordered domains in model lipid membranes would indicate that 
lipid-lipid and lipid-cholesterol interactions are sufficient to produce liquid-ordered 
domains with dimensions similar to those that may exist in biological membranes.  
Despite the significance of such a finding, whether the nanoscale heterogeneity 
detected in membranes composed of DLPC, DSPC, and a threshold cholesterol 
concentration is due to the presence of liquid-ordered domains, gel-phase domains, 
or non-ideally mixed transient lipid assemblages has not been definitively 
established. 
A key difference between phase-separated domains and non-ideally mixed 
transient lipid clusters is that the composition and microstructure would be constant 
between nanoscopic phase-separated domains of the same phase, as opposed to 
varying from one structure to another in non-ideally mixed lipid assemblages.18 
Liquid-ordered and gel-phase domains can be discriminated by their microstructures, 
as the edges of liquid-ordered domains are smooth and rounded, whereas the 
perimeters of gel-phase domains are angular and jagged.18,25,26,29 The membrane 
thickness may also differ between gel-phase and liquid-ordered domains.30 
Therefore, information on the composition and microstructure of individual domains is 
required to identify whether the lipid structures detected at the threshold cholesterol 
concentration are non-ideally mixed lipid assemblages or phase-separated domains 
in the gel- or liquid-ordered phase. The microstructure, and therefore phase, of 
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submicron-sized lipid assemblages within supported lipid bilayers can be 
characterized with atomic force microscopy (AFM) even when the domain sizes are 
below the lateral resolution of conventional fluorescence microscopy.17,19,23,25,31,32 
Assessing the lipid composition of individual lipid domains is more challenging 
because few analytical techniques yield spatially resolved and chemically specific 
information. Secondary ion mass spectrometry (SIMS) is one of the few approaches 
that enables imaging specific lipid species within supported lipid membranes with 
both chemical and spatial specificity.32-42 Time-of-flight SIMS (TOF-SIMS) is a 
molecular imaging approach that has the advantage of not requiring labels for lipid 
identification, but the lateral resolution and sensitivity is seldom sufficient to 
characterize submicron-sized lipid domains.43 Recently, a combination of high-
resolution SIMS performed with a Cameca NanoSIMS 50 and lipid-specific isotope 
labeling has permitted the distributions of two isotopically labeled lipid species in 
phase-separated supported lipid membranes to be imaged with 100-nm-lateral 
resolution and quantified, rendering this a promising approach to analyze the lipid 
composition within nanoscopic lipid domains (diameters <300 nm).36  The Cameca 
NanoSIMS 50 is a magnetic sector mass spectrometer that can image differences in 
elemental and isotopic composition.44 To identify and image different lipids using a 
NanoSIMS, each lipid species must contain a distinct stable isotope so that the 
secondary ions generated during analysis can be linked to the parent lipid species.44 
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In this chapter, we use AFM and NanoSIMS to characterize the effects of 
cholesterol addition on the microstructure and composition of lipid domains in ternary 
membranes composed of the saturated, low Tm lipid 15N-1,2-dilauryl-sn-glycero-3-
phosphocholine (15N-DLPC), and the high Tm lipid 1,2-distearoyl-D70-sn-glycero-3-
phosphocholine (D70-DSPC).  We investigated cholesterol concentrations between 0 
and 19 mol%. Over this range of cholesterol concentrations, GUVs composed of 
DLPC/DSPC exhibit macroscopic phase-separated domains and nanoscale 
heterogeneous mixing that is postulated to signify the presence of tiny liquid-ordered 
domains.18,26 Supported lipid membranes are the subject of these studies to permit 
analyses with NanoSIMS and AFM. Although discrepancies in the phase behavior of 
supported membranes and GUVs have been reported, we avoided the non-
equilibrium effects potentially induced by the solid support by using slow-cooled 
vesicle fusion to prepare the supported membranes, as demonstrated by Longo and 
co-workers.23,25 Analysis of the same regions of the membrane with both AFM and 
NanoSIMS enabled correlation of domain microstructure with lipid composition, and 
allowed us to assess whether the nanoscopic lipid assemblages that occur near the 
threshold cholesterol concentration are non-ideally mixed clusters, or phase-
separated lipid domains in either a gel or liquid-ordered state. As shown later, the 
AFM and NanoSIMS data indicate that the nanoscopic lipid assemblies within the 19 
mol% cholesterol membrane are gel-phase domains.  
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Results and Discussion 
 The cooling rate employed for bilayer formation determines whether the 
phase-separation approaches equilibrium. All of the samples we studied were cooled 
to room temperature at the same rate to ensure that any variations in domain 
morphology were not due to differences in their thermal history. For compatibility with 
NanoSIMS analysis, the room temperature 15N-DLPC/D70-DSPC/cholesterol 
supported lipid membranes were flash-frozen and freeze-dried to remove the water 
without perturbing lipid organization.37 Previous studies demonstrated that flash-
freezing and freeze-drying does not induce further phase-separation or other 
changes in membrane organization, and the preserved membrane structure reflects 
that present at room temperature prior to membrane preservation.37 The lipids in the 
membrane do not exhibit lateral mobility after freeze-drying, and the membrane 
organization does not change in the time between AFM imaging and NanoSIMS 
analysis (2 – 6 weeks). Note that the use of isotopically labeled lipids is not expected 
to alter membrane phase behavior because D70-DSPC has nearly the same Tm as 
natural abundance DSPC (50.5 °C and 55.0 °C, respectively45), and the single 
nitrogen-15 isotope in 15N-DLPC should not affect its Tm.  
 
Cholesterol-free phase-separated supported lipid membranes 
To correlate domain structure with lipid composition, we imaged the same 
locations within the phase-separated supported lipid membrane using both AFM and 
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NanoSIMS. Similar to previous AFM studies of phase-separated supported lipid 
membranes, we observed circular gel-phase domains with a bimodal size distribution 
in the cholesterol-free membrane (Figure 2.2).32,37,46 Small gel-phase domains with 
diameters below 200 nm were primarily located near the perimeters of the large gel-
phase structures that were several microns in diameter (Figure 2.2a-c). Nanoscopic 
fluid-phase subdomains were also trapped inside of the micron-sized gel-phase 
domains. We measured a height difference of 1.3 nm at the interface between the 
gel- and fluid-phase domains (Figure 2.2b, inset). This height difference is smaller 
than that previously reported between gel- and fluid-phase domains (1.8 nm) and is 
closer to the height difference between an asymmetric domain, with one gel-phase 
and one fluid-phase leaflet, and a symmetric fluid-phase domain.37,46 However, 
NanoSIMS analysis of these domains (Figure 2.2d-f) indicated they contain too little 
15N-DLPC to be asymmetric 15N-DLPC/D70-DSPC domains (see later). The smaller 
height difference we measured between the gel- and fluid-phases is likely due to our 
use of a repulsive tip-sample interaction for AFM imaging.47 AFM imaging of similar 
samples performed with a repulsive tip-sample interaction yielded a height difference 
of 1.3 nm at the gel/fluid interface, but with a tip-sample interaction that fluctuated 
between repulsive and attractive, we measured a height difference of 1.6 nm at the 
same location (not shown), which is close to the 1.8 nm height difference as 
previously reported.37,46 
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Figure 2.2. AFM (a and b) and high-resolution SIMS images (d and e) of a phase-separated 
supported lipid membrane containing an equal molar ratio of D70-DSPC and 15N-DLPC without 
cholesterol. (a) AFM image shows gel- and fluid-phase membrane domains. (b) Higher resolution AFM 
image of the region outlined in (a). The line scan below the AFM image was acquired at the location 
indicated by the dashed line. (d) The NanoSIMS images showing an overlay of the normalized 12CD- 
(red) and 12C15N- (green) ion signals that localize D70-DSPC and 15N-DLPC, respectively, were 
acquired at the same site as the AFM image (a). The absence of lipid-specific ions at the regions that 
appear dark is due to the low intensity of the minor isotopes.  (e) Detail of the region outlined in (a), 
which corresponds to the AFM image in (b). Additional AFM and NanoSIMS images (c and f) taken at 
a different membrane region. The NanoSIMS images were acquired with ~100-nm-lateral resolution 
and smoothed over a lateral resolution of ~150 nm. 
 
The NanoSIMS analysis was performed at the same membrane locations that 
were imaged with AFM. The normalized 12CD- ions (red) and 12C15N- ions (green) 
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were used to locate D70-DSPC and 15N-DLPC, respectively. The absence of lipid-
specific ions at some pixels is due to the low intensity of the minor isotopes, as the 
AFM image of the freeze-dried membrane does not show damage at these sites 
(Figure 2.2a-c). Similar to previous reports, the area occupied by D70-DSPC within 
the membrane appeared to be slightly lower than that expected based on the mol% 
D70-DSPC in the vesicles used for membrane preparation.37 This difference in the 
D70-DSPC content within the supported membranes and the phase-separated lipid 
membranes is likely due to the selective adsorption of these different lipid species 
onto the substrate, or from a lipid exchange process.25,48 
 
Figure 2.3. Calibration curve correlating the normalized 12C15N- ion intensity to the mol% 15N-DLPC in 
the membrane, constructed by performing several NanoSIMS measurements on homogeneous lipid 
membranes of known mol% 15N-DLPC. Error bars represent one standard deviation around the mean. 
 
Using the NanoSIMS calibration curves described later (Figure 2.3), we 
determined that the 15N-DLPC concentration was ~97 mol% in the fluid-phase 
domains, and ~6 mol% in the gel-phase domains. Because NBD-PC (see Materials 
and Methods section) is excluded from the gel-phase,25,48 the D70-DSPC 
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concentration in the gel-phase regions of the cholesterol-free membrane is ~94 
mol%. These results are consistent with previous NanoSIMS studies of DLPC/DSPC 
membranes and phase diagram predictions that the gel-phase contains ≤10 mol% 
DLPC and the fluid-phase contains ≤10 mol% DSPC.37,49 The one exception was at 
the edges of the large gel-phase domains, where the data occasionally suggest the 
fractions of D70-DSPC and 15N-DLPC within the same pixel (yellow areas, Figure 
2.2d-f) were more nearly equal. This might suggest that the amount of lipid mixing at 
the edges of the domains was greater than that predicted by phase-diagrams. 
However, the AFM images acquired at these sites show the edges of the gel-phase 
domains are not smooth, but instead consist of many small crevices and peninsulas.  
Thus, the detection of elevated amounts of D70-DSPC and 15N-DLPC at the same 
pixel occurred because these structures were not resolved in these NanoSIMS 
images, which were acquired with a beam diameter of ~100 nm and were smoothed 
to the equivalent of ~150 nm lateral resolution.  
 
Phase-separated supported lipid membranes with 3 - 15 mol% cholesterol  
The addition of cholesterol to the membrane induced an elongation of the 
macroscopic gel-phase domains. At 3 mol% cholesterol, the macroscopic D70-DSPC-
enriched gel-phase domains were oblong and had jagged borders (Figure 2.4). A 
network of gel-phase domains was observed at 7 mol% cholesterol (Figure 2.5). 
Similar to the cholesterol-free membrane, fluid-phase subdomains were entrapped 
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within the macroscopic gel-phase structures, and gel-phase microdomains were 
dispersed throughout the fluid phase in the 3 and 7 mol% cholesterol membranes. A 
networked gel-phase structure that contained entrapped fluid-phase subdomains was 
also observed in the 15 mol% cholesterol membrane, but the edges of the gel-phase 
structures were smoother than those observed in the other membranes (Figure 2.6). 
The area occupied by the D70-DSPC-rich domains in the membranes that contained 7 
and 15 mol% cholesterol was higher than that expected based on the compositions 
of the vesicles used for membrane formation. This difference in surface coverage 
was consistent across the membrane (see additional images in Figure 2.6). We 
attribute these results to the phenomena occurring during bilayer formation, such as 
the selective adsorption of the lipids species onto the substrate or lipid exchange, as 
opposed to selective incorporation of cholesterol into the ordered domains, because 
cholesterol is expected to evenly distribute between the two lipid phases.14 Moreover, 
the increase in D70-DSPC domain surface coverage seems larger than the fraction of 
cholesterol in the membrane. The height difference between the gel- and fluid-phase 
regions of the 3, 7, and 15 mol% cholesterol membranes did not change from that 
measured in the cholesterol-free membrane (~1.3 nm). Similarly, the 15N-DLPC 
concentration within the D70-DSPC-enriched domains remained constant at ~6 mol%, 
indicating that the solubility of 15N-DLPC within the D70-DSPC-rich domains did not 
change over this range of cholesterol concentrations. We did not attempt to quantify 
the mol% of 15N-DLPC in the fluid phase due to the high likelihood that the numerous 
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nanoscopic gel-phase domains detected within the fluid phase by AFM would 
inadvertently be included in the measurement. 
 
Figure 2.4. AFM (a-c) and corresponding high-resolution SIMS (d-f) images of phase-separated 
membranes composed of a 1:1 molar ratio of D70-DSPC to 15N-DLPC and 3 mol% cholesterol. The line 
scan below the AFM image in (a) was taken at the area indicated by the dashed line. Additional AFM 
and NanoSIMS images (b and c, and e and f, respectively) taken at a different membrane region. The 
NanoSIMS images were acquired with ~100-nm-lateral resolution and smoothed over a lateral 
resolution of ~150 nm. 
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Figure 2.5. AFM (a-c) and corresponding high-resolution SIMS (d-f) images of phase-separated 
membranes composed of a 1:1 molar ratio of D70-DSPC to 15N-DLPC and 7 mol% cholesterol. The line 
scan below the AFM image in (a) was taken at the area indicated by the dashed line. Additional AFM 
and NanoSIMS images (b and c, and e and f, respectively) taken at a different membrane region. The 
NanoSIMS images were acquired with ~100-nm-lateral resolution and smoothed over a lateral 
resolution of ~150 nm. 
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Figure 2.6. AFM (a-c) and corresponding high-resolution SIMS (d-f) images of phase-separated 
membranes composed of a 1:1 molar ratio of D70-DSPC to 15N-DLPC and 15 mol% cholesterol. The 
line scan below the AFM image in (a) was taken at the area indicated by the dashed line. Additional 
AFM and NanoSIMS images (b and c, and e and f, respectively) taken at a different membrane 
region. The NanoSIMS images were acquired with ~100-nm-lateral resolution and smoothed over a 
lateral resolution of ~150 nm. 
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Figure 2.7. AFM (a-c) and correlated high-resolution SIMS (d-f) images of a phase-separated 
membrane composed of a 1:1 molar ratio of D70-DSPC to 15N-DLPC and 19 mol% cholesterol. AFM 
images (a and b) of two different areas of the phase-separated membrane and corresponding SIMS 
images (d and e, respectively). (c) Higher resolution AFM scan of the area outlined with a rectangle in 
(b). The line scan below (c) was acquired at the edge of a cluster of nanoscopic domains, indicated by 
the dashed line in (c). The line scan below (f) was acquired at the nanoscopic lipid domain indicated 
by the circle in (c). (f) Enlarged SIMS image of the area indicated by the black rectangle in (b), which 
corresponds to the AFM image in (c). The NanoSIMS images were acquired with ~100-nm-lateral 
resolution and smoothed over a lateral resolution of ~150 nm. 
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Supported lipid membranes containing 19 mol% cholesterol and greater 
Our AFM and NanoSIMS images of the 19 mol% cholesterol membrane 
clearly show heterogeneity in membrane composition and structure (Figure 2.7). 
Individual and micron-sized aggregates of nanoscopic ordered domains enriched with 
D70-DSPC are visible in the membrane. The height difference measured with AFM 
between the gel- and fluid-phases in the 19 mol% cholesterol membrane did not vary 
with domain size (~1.2 nm), and was similar to those measured in membranes with 
lower cholesterol levels (~1.3 nm). The 15N-DLPC concentration within the 
submicron-size domains that were resolved in the NanoSIMS images was ~7 mol%, 
within one standard deviation of the value measured on the 0 – 15 mol% cholesterol 
membranes. Thus, a significant increase in lipid intermixing did not occur in these 
domains. However, elevated amounts of D70-DSPC and 15N-DLPC were detected at 
the same pixel more frequently in the 19 mol% cholesterol membrane than in the 
other membranes (yellow areas, Figure 2.7d-f). Comparison to the AFM images 
acquired at these locations revealed the presence of nanoscopic lipid structures that 
were smaller than the resolution of the NanoSIMS images (Figure 2.7a-c). Therefore, 
the detection of significant amounts of D70-DSPC and 15N-DLPC at the same pixel in 
the 19 mol% cholesterol membrane signifies the presence of a phase-separated 
domain that is smaller than the lateral resolution of the NanoSIMS image. The lack of 
an observable change in the height of the nanoscopic lipid structures or lipid 
intermixing denotes the presence of phase-separated domains, and not non-ideally 
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mixed lipid clusters, in the 19 mol% cholesterol membrane. Because AFM imaging 
also shows that both the micron-sized and nanoscopic lipid domains have irregular 
borders, we conclude that the domains enriched with D70-DSPC remained in the gel-
phase at 19 mol% cholesterol.   
We also attempted to characterize supported lipid membranes that contained 
>19 mol% cholesterol (27 and 35 mol% cholesterol). These membranes exhibited 
numerous small height changes (<1 nm) and taller features indicative of debris by 
AFM, whereas patches of 15N-DLPC and very little D70-DSPC were detected on the 
substrate using the NanoSIMS (not shown). These features are not characteristic of 
those we have observed in poorly preserved membranes, nor do they resemble the 
dehydration-induced defects characterized by others.50 These results suggest that 
high-quality supported lipid membranes did not form under the same conditions as 
those used to create the membranes with lower mol% cholesterol.  
  
Lipid organization in 15N-DLPC/D70-DSPC/cholesterol membranes 
Using a combination of AFM and high-resolution SIMS to acquire correlated 
information on the structure and lipid distribution within 15N-DLPC/D70-
DSPC/cholesterol membranes at room temperature, we found that the addition of up 
to 19 mol% cholesterol induced significant changes in domain morphology, but it 
produced no observable change in the miscibility of 15N-DLPC within the gel-phase. 
Unlike previous results in which the phase behavior of analogous supported 
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membranes differed from that of GUVs,23 our results are in agreement with those 
reported for DLPC/DSPC/cholesterol GUVs and mica-supported membranes.26,28 
This good agreement indicates that the slow-cooled vesicle fusion process we 
employed for membrane formation likely allowed the membrane to approach 
equilibrium, and neither the silicon substrate nor the isotope labels appeared to alter 
membrane phase behavior.  
According to the DLPC/DSPC/cholesterol phase diagram (Figure 2.1), the 
miscibility point for a 1:1 molar ratio of DLPC/DSPC is ~19 mol% cholesterol, and 
non-ideal mixing postulated to be caused by nanoscopic, liquid-ordered domains has 
been previously detected with FRET at slightly higher cholesterol concentrations 
(between 20 and 25 mol%).18,26 Yet gel-phase domains were present in our 
supported lipid membranes composed of DLPC/DSPC (1:1 molar ratio) and 19 mol% 
cholesterol. A higher amount of D70-DSPC than 15N-DLPC in the membrane, which 
could have occurred due to small gravimetric and volumetric errors in measuring the 
lipids, would shift the miscibility point to a higher cholesterol concentration (~20 
mol%) than we studied.26 However, we expect that nanoscopic gel-phase domains 
would also be present in our membranes at 20 – 21 mol% cholesterol because we 
detected a small number of micron-sized, gel-phase domains at 19 mol% cholesterol 
(Figure 2.7a and b, lower left), and the gel-phase domains in supported lipid 
membranes undergo a reduction in size due to domain pinning before complete 
miscibility is reached.19,28 This expectation is supported by a recent report by Gosku 
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and Longo.28 The speckling in Gosku and Longoʼs fluorescence microscopy images 
of mica-supported DLPC/DSPC/cholesterol (40/40/20 mol:mol:mol) membranes 
suggests the presence of tiny phase-separated domains that could be detected by 
AFM, but are too small to be clearly visualized with fluorescence microscopy.28 We 
hypothesize that the small inconsistency in the location of the boundary for phase 
separation between our results and the published DLPC/DSPC/cholesterol phase 
diagram is due to the difference in techniques used to detect phase separation, as 
the AFM and NanoSIMS techniques we used are better suited to unambiguously 
detect submicron-sized domains than the conventional fluorescence 
microscopy.16,23,26,28  
The fusion of DLPC/DSPC (1:1 mol ratio) vesicles that contained 27 and 35 
mol% cholesterol to the silicon substrates under conditions identical to those 
employed for the other cholesterol concentrations did not produce continuous, defect-
free membranes. Increasing the cholesterol concentration within vesicles composed 
of phase-separating lipids is reported to hinder vesicle rupture, causing an increase 
in the critical number of vesicles that must adsorb to the silicon substrate in order to 
initiate vesicle fusion.51 Because others have used vesicle fusion to form 
DLPC/DSPC (1/1 mole ratio) membranes that contained 30 mol% cholesterol on 
mica substrates,28 we hypothesize that the vesicle concentration or incubation time 
we employed for vesicle fusion was insufficient for the formation of defect-free 
membranes that contained 27 or 35 mol% cholesterol.   
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Significance and implications 
Our data indicate that interactions between saturated lipids, such as DLPC 
and DSPC, and cholesterol are insufficient to drive the formation of liquid-ordered 
domains that are similar to those expected to exist within biological membranes. Our 
results, and those reported by others, suggest that molecular interactions between 
the fluid-phase lipid and cholesterol affect the structure of the ordered lipid domains 
that form in the membranes.19,25 Although the DLPC/DSPC/cholesterol membranes 
we studied are not compositionally or biophysically representative of biological 
membranes, our findings do provide insight into the physiological significance of fatty 
acid chain saturation in biological membranes. Specifically, our results support the 
hypothesis that the presence of unsaturation in the fatty acid chains of the low-
melting lipids found in biological membranes is required for the formation of a liquid-
ordered phase. Furthermore, we propose that the absence of saturated, low Tm lipids 
in cellular membranes is functionally significant, as their presence may hinder the 
formation of liquid-ordered membrane domains. 
This work also establishes a direct approach to acquire correlated information 
on the microstructure and composition of individual lipid domains. This approach 
could be extended to quantifying the amounts of DSPC and cholesterol in the lipid 
domains detected in these membranes by also incorporating a different distinct stable 
isotope into the cholesterol, and creating separate calibration curves for DSPC and 
cholesterol using sets of standard lipid membrane samples. Such studies would 
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permit identifying whether the cholesterol concentration is equal in both lipid phases, 
as indicated by original experiments,14 or if the cholesterol concentration is higher in 
the ordered domains, as found for other lipid mixtures.18 Our approach could also be 
used to construct more detailed phase diagrams that include tie lines for 
DLPC/DSPC/cholesterol or other more physiologically relevant lipid mixtures.  Such 
studies may clarify uncertainties in membrane phase behavior, and provide a better 
understanding of how cholesterol-dependent interactions contribute to cell membrane 
organization. 
 
Conclusions 
By analyzing the same locations in supported lipid membranes with AFM and 
high-resolution SIMS, we were able to acquire correlated information on the 
microstructure and composition of the individual lipid domains found in the 
membranes at room temperature. We showed that the nanoscopic, D70-DSPC 
domains present in the 19 mol% cholesterol membrane were in the gel phase. The 
15N-DLPC concentration in the D70-DSPC domains was relatively constant (6 – 7 
mol%) for cholesterol concentrations between 0 and 19 mol%, indicating that 
cholesterol did not induce a significant increase in lipid intermixing in these domains. 
Our results support the finding of Zhao et al. that nanoscopic, phase-separated 
domains are present in the membrane at ~19 mol% cholesterol,26 but we found no 
evidence for the presence of liquid-ordered domains. We conclude that the 
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interactions between cholesterol and saturated lipids, such as DLPC and DSPC, are 
not sufficient to create liquid-ordered domains.  Consequently, the absence of 
saturated, low-melting lipids in biological membranes may be required for the 
formation of the liquid-ordered domains that are expected to exist in cellular 
membranes.  
 
Materials and Methods 
Materials  
The chrome-patterned, oxidized silicon substrates (10-nm-thick oxide layer) 
were prepared as previously described37 using silicon wafers that were a generous 
gift from Prof. Steven G. Boxer (Stanford University, Stanford, CA). The lipids 1-
palmitoyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]lauroyl}-sn-glycero-3-
phosphocholine (NBD-PC) and D70-DPSC were purchased from Avanti Polar Lipids, 
Inc (Alabaster, AL), and (15N-DLPC) was synthesized as reported.37 To minimize 
possible oxidation, cholesterol was freshly synthesized from i-cholesteryl methyl 
ether (Sigma) as reported.52 The cholesterol and phospholipid concentrations in the 
vesicle solutions were measured with the Amplex® Red Cholesterol Assay Kit and 
the Amplex® Red Phospholipase D Assay Kit, respectively, from Molecular Probes 
(Eugene, OR). Millipore (18 mΩ) water was used in all experiments.  
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Preparation of supported lipid membranes  
Small unilamellar vesicles were created from an equal molar ratio of 15N-DLPC 
(Tm = -1 °C) to D70-DPSC (Tm = 50.5 °C45), and approximately 0, 2.5, 5, 10, 15, 20, or 
35 mol% cholesterol. The actual cholesterol concentrations in the final vesicle 
solutions measured with enzymatic assays (see section below) were 0, 3, 7, 15, 19, 
27, and 35 mol%.  A small amount (1 mol%) of the fluorescent lipid, NBD-PC, was 
added to the mixture to allow the evaluation of membrane integrity and the presence 
of phase separation using fluorescence microscopy. These components were 
dissolved in chloroform, dried under nitrogen, and placed under vacuum to remove 
residual chloroform. The lipid film was resuspended in 65 °C water to a final lipid 
concentration of 0.5 mg/mL.  The lipid solution was heated in a 65 °C water bath for 
15 min, vortexed, transferred to a plastic tube, and sonicated using a tip sonicator 
(Branson Tip Sonifier Model 250, Branson Ultrasonics, Danbury CT) for 30 s intervals 
until it became transparent. The vesicle solution was reheated to 65 °C in a water 
bath, and 2.5 mL of 65 °C vesicle solution was added to a 60-mm-diameter x 15-mm-
tall polystyrene culture dish containing multiple chrome-patterned, oxidized silicon 
substrates submerged in 2.5 mL of 65 °C water. The culture dish was covered, 
incubated at room temperature for 40 min to allow for bilayer formation, and then was 
transferred into a 65 °C water bath. The substrates were gently shaken under water 
to dislodge vesicles adhered to the bilayerʼs surface, and were transferred to a fresh 
65 °C water bath. The water bath containing the substrates was placed in a 
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programmable oven (ECHOterm™ IN35 Programmable Chilling/Heating Incubator, 
Torrey Pines Scientific, San Diego, CA), maintained at 70 °C for 1 h, and then was 
slowly cooled to room temperature at a rate of 5 ˚C/h to induce phase separation. To 
prepare the lipid membranes for SIMS analysis, the samples were flash-frozen in 
liquid ethane and freeze-dried as previously described.35-37 To evaluate sample 
quality, fluorescence imaging was performed on a Leica DM6000 B upright 
fluorescence microscope equipped with a fluorescence filter cube (GFP, Leica) that 
matches the excitation and emission spectra for NBD-PC. 
 
Measurement of mol% cholesterol  
The moles of cholesterol and phosphatidylcholine (PC) in each vesicle solution 
were measured using the Amplex® Red Cholesterol Assay Kit and the Amplex® Red 
Phospholipase D Assay Kit, respectively. The assays were performed in 96-well 
plates purchased from Costar® (Corning, NY), and the fluorescence intensity was 
read using a Synergy HT Multi-Mode Microplate Reader Model SIAFRT (Biotek® 
Instruments, Inc., Winooski, VT). Cholesterol and PC standards were used to create 
the calibration curves. Eight replicates were performed on each vesicle and standard 
solution. The µmole of cholesterol and PC measured in each small unilamellar 
vesicle solution was used to calculate the mol% of cholesterol. The mol% cholesterol 
in the supported lipid membranes is assumed to be the same as the cholesterol 
content in the vesicle solution used for bilayer formation. 
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AFM imaging of lipid membranes  
 AFM analysis was performed in ambient air and temperature using an Asylum 
MFP-3D™ Stand Alone AFM. AFM images were acquired of the phase-separated 
membranes within specific grid boxes, which were relocated and analyzed with the 
NanoSIMS. Measurements were taken with standard tapping 300 kHz AFM probes 
(Tap300Al-G, Budget Sensors, Bulgaria) in AC (tapping) mode operated in the 
repulsive tip-sample interaction regime to preserve tip lifetime. Images were flattened 
to the first order. The line scans were averaged over three pixels perpendicular to the 
line-section path to minimize random variations in height due to noise. The line scans 
made on the 19 mol% cholesterol membrane were not averaged because the 
domains were often smaller than the 3-pixel averaging width. For each cholesterol 
concentration investigated, the height difference between the gel- and fluid-phase 
regions was measured at ten different domain interfaces. 
 
High-resolution SIMS analysis  
SIMS was performed on a Cameca NanoSIMS 50 instrument (Cameca, 
France) at Lawrence Livermore National Laboratory (Livermore, CA). Measurements 
were made with a ~0.8 pA, 16 keV Cs+ primary ion beam focused onto a ~100 nm-
diameter spot with an analysis area of 25 µm x 25 µm. A beam diameter of 102 nm 
was determined using the reported knife-edge method.37 Measurements consisted of 
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six replicate scans of 512 x 512 pixels with a dwell time of 0.3 ms/pixel, and 
corresponded to a primary ion dose of ~3.8 x 1014 ions/cm2. The analysis conditions 
used in this work were chosen to provide sufficient ion counts to characterize the 
samples while minimizing analysis time. Based on our analysis conditions, a total 
sputter time of 472 s, and the sputtering rate of 2.5 nm·μm2/pA·s determined on other 
biological samples,53 we estimate that the sputtering depth was ~1.5 nm for these 
measurements. Based on the thickness of the bilayer, the analysis time could have 
been ~3 times longer, though the secondary ion intensities obtained in each 
additional replicate scan would be lower than the previous scan. The pixel size in the 
NanoSIMS ion images was 49 nm x 49 nm, which is smaller than the beam diameter. 
The secondary ion signals 12C-, 12CD-, and 12C15N-, and the secondary electron signal 
were collected simultaneously using multi-collection mode. A mass resolving power 
of ~7500 was used to separate isobaric interferences from the isotopes of interest, 
e.g., 12C2H from 13C1H and 12C1H2 at a nominal mass of 14 amu, and 12C15N from 
13C14N at a nominal mass of 27 amu. Data were analyzed using a custom software 
package (L′image, L.R. Nittler, Carnegie Institution of Washington) run on the PV-
Wave platform (Visual Numerics, Inc., Houston, TX). The lipid-specific ions (12CD- 
and 12C15N-) were smoothed over 3 x 3 pixels (147 nm x 147 nm). Then the lipid-
specific ion signal was normalized by dividing the intensity for each ion by the 12C- 
intensity measured at the same pixel in order to minimize random, concentration-
independent changes in the signal intensity. Regions of interest (ROIs) on the 
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calibration set of homogeneous lipid membranes were defined on areas of the 
substrate that were covered by the membrane, and excluded areas where the 
chrome grid or obvious defects were visible in the secondary electron image that was 
collected in parallel to the secondary ion images. ROIs on the phase-separated 
membranes that consisted of only gel-phase or fluid-phase regions were defined 
based on the correlated AFM images. 
 
Determination of lipid composition within lipid phases   
 A calibration curve correlating the normalized 12C15N- secondary ion intensity 
to the mol% 15N-DLPC in the membrane was made as previously reported.36, 37 
Briefly, NanoSIMS analysis was performed on homogeneous lipid bilayers that 
systematically varied in mol % 15N-DLPC to unlabeled DLPC. These samples were 
used instead of 15N-DLPC/cholesterol membranes in order to obtain a calibration 
curve that was accurate at both high and low 15N-DLPC concentrations. The same 
analytical conditions were used for the calibration and phase separated samples. We 
assessed the validity of these calibration samples by calculating the relative 
sensitivity factors (RSF)39 for the 12C15N- using 12C- as the reference ion. For 
membranes composed of 15N-DLPC/NBD-PC (99/1 mol%:mol%), 15N-
DLPC/cholesterol/NBD-PC (84/15/1 mol%/mol%/mol%), and 15N-
DLPC/cholesterol/NBD-PC (69/30/1 mol%/mol%/mol%), the RSF for 12C15N- was 
0.0089 ± 0.0003, 0.0093 ± 0.0017, and 0.0093 ± 0.0011, respectively. Note that 
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these values are low because the intensity of the 12C- reference ion is very high. 
Because the RSF for 12C15N- was ~ 4.5% higher in the presence of cholesterol, we 
expect that the mol% 15N-DLPC that we calculate in membranes containing 
cholesterol may be overestimated by up to 5 mol%.   
 To create the calibration curve, the normalized 12C15N- intensity (12C15N-/12C-) 
was measured for several ROIs so that an area of at least 1000 μm2 was analyzed 
on each homogeneous membrane sample of specified mol% 15N-DLPC. The mean 
values and standard deviation of the normalized 12C15N- signal were calculated for 
each mol% 15N-DLPC. The normalized 12C15N- intensity was plotted against the mol% 
15N-DLPC in the membrane (Figure 2.3) where the error bars show one standard 
deviation, and the best-fit line for the calibration data was calculated by linear 
regression. For every cholesterol composition studied, the amount of 15N-DLPC in the 
gel-phase was determined using the calibration curve to convert the normalized 
12C15N- intensity measured within gel-phase regions where trapped fluid-phase 
subdomains were not detected by AFM into mol% 15N-DLPC. The normalized 12C15N- 
intensity was measured at several ROIs on each sample, and the average mol% 15N-
DLPC in the gel-phase and standard deviation were calculated. Because NBD-PC is 
excluded from the gel-phase,37,46 the average amount of D70-DSPC in the gel-phase 
regions of the cholesterol-free membrane was determined by subtracting the mol% 
15N-DLPC measured at membrane locations identified as gel-phase by AFM from 100 
mol%.  
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Chapter 3.  
DISCRIMINATING AND IMAGING DIFFERENT 
PHOSPHATIDYLCHOLINE SPECIES WITHIN PHASE-
SEPARATED MODEL MEMBRANES BY PRINCIPAL 
COMPONENT ANALYSIS OF TOF-SIMS IMAGES 
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Introduction 
Comprehensive characterization of lipid mixing behavior within model lipid 
membranes provides valuable information on how lipid-lipid interactions may 
contribute to cell membrane organization and function.2,3 The biophysical and 
structural properties of model lipid membranes are routinely probed by using 
fluorescence microscopy and atomic force microscopy.4-8 Spatially resolved 
compositional information that complements this biophysical and structural data is 
also essential for understanding biological membrane organization, but is presently 
more difficult to acquire. The lipid distribution within model membranes can be 
imaged in a chemically specific manner by using secondary ion mass spectrometry 
(SIMS).9-21 However, additional advances in SIMS methodologies are necessary to 
improve the specificity, sensitivity, and lateral resolution of lipid identification and 
imaging in label-free systems. 
Time-of-flight SIMS (TOF-SIMS) is a molecular imaging technique that reveals 
the chemical composition at the surface of a sample with as high as submicron lateral 
resolution.11,22,23 For the analysis of lipid membranes using TOF-SIMS, lipid 
components are usually identified according to a limited number of characteristic lipid 
fragment ions in the mass spectra, such as those corresponding to lipid headgroups, 
fatty acids, and backbone segments.9,10,14-17,24,25 However, the use of these types of 
fragment ions to discriminate between structurally similar lipids, such as different 
phosphatidylcholine species, is especially problematic. Though low molecular weight 
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fragment ions (i.e., phosphocholine and hydrocarbon ions) generate sufficient ion 
yields to achieve submicron lateral resolution, these ions are common to many 
structurally similar lipid species, prohibiting their use for species identification. 
Molecular ions and large fragment ions may be unique to a single component, but 
they usually have very low yields that compromise the working lateral resolution of 
the resulting TOF-SIMS image.10,26 Structurally similar lipids can be endowed with 
characteristic fragment ions through the use of stable isotope labeling,10,16,18-21,24,26 
but label-free approaches are desired to facilitate sample preparation and SIMS 
analysis of native cell membranes. 
Principal component analysis (PCA) is a multivariate analysis technique that is 
used to identify linear combinations of multiple mass peaks that exhibit similarities 
and differences in the TOF-SIMS data acquired from different samples.27,28 Because 
PCA distinguishes the spectra according to variations in the relative intensities of 
many TOF-SIMS mass peaks, the abundant low mass ions that are common to 
structurally similar molecules, and thus, not utilized for univariate spectra 
interpretation, can be exploited for component identification.28 This use of a larger 
fraction of the TOF-SIMS mass peaks for component identification increases image 
contrast and improves the specificity of component identification.27-30 The TOF-SIMS 
spectra of structurally similar molecules, including monosaccharide 
stereoisomers,31,32 proteins,33,34 and alkane thiols,35 have been successfully 
discriminated using PCA.  PCA has also been used to identify unlabeled lipids with 
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different headgroups and deuterated lipids in model membranes by their TOF-SIMS 
data.26,29 However, successfully discriminating the TOF-SIMS data from unlabeled 
structurally similar lipid species (i.e., lipids with the same headgroups and degrees of 
saturation in the fatty acid tails) using PCA has not been reported.  
In this chapter, we investigate the ability to distinguish and image structurally 
similar lipids within supported lipid membranes by using PCA to interpret TOF-SIMS 
images.  Because high mass ions have low intensities in the spectra acquired from 
lipid membranes with TOF-SIMS, we first evaluate the feasibility of discriminating four 
different unlabeled saturated phosphatidylcholine species that are frequently studied 
in model membranes, 1,2-dilauroyl-sn-glycero-3-phosphocholine (DLPC), 1,2-
dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 1,2-dipalmitoyl-sn-glycero-3-
phosphocholine (DPPC), and 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), by 
PCA of the low mass ions (m/z ≤200) in the TOF-SIMS data. Discrimination of these 
lipid species by TOF-SIMS is especially challenging because each contains a 
phosphocholine headgroup, glycerol backbone, and two saturated fatty acid tails that 
differ only in length (12, 14, 16, and 18 carbons per fatty acid in DLPC, DMPC, 
DPPC, and DSPC, respectively). Next, we assess whether each lipid species within 
supported lipid membranes composed of DSPC/DLPC and DPPC/DLPC can be 
differentiated, visualized, and chemically identified by PCA of TOF-SIMS images.  
These lipid mixtures were selected because they are known to phase-separate into 
DLPC-rich fluid-phase domains, and DSPC- or DPPC-rich gel-phase domains at 
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room temperature.18,21,35,36 In addition, the chemically specific SIMS imaging of the 
lipid organization within these membranes has only been accomplished by using 
stable isotope labeling.18,21 To evaluate whether the principal component (PC) scores 
images generated from the TOF-SIMS images of the phase-separated membranes 
show the sizes and shapes of the gel- and fluid-phase domains, we compare the PC 
scores images to AFM images of the phase-separated domains that were acquired at 
the same membrane locations prior to TOF-SIMS analysis. Finally, we investigate 
whether the lipid composition at these distinct locations can be identified by 
projecting their TOF-SIMS data onto PC models developed using spectra from lipid 
standards. 
 
Results and Discussion 
PCA discrimination of TOF-SIMS spectra of saturated phosphatidylcholine species 
Representative TOF-SIMS positive ion mass spectra of four saturated 
phosphatidylcholine species are shown in Figure 3.1. The unique mass peaks that 
could be used to discriminate DLPC, DMPC, DPPC, and DSPC include the molecular 
ions (m/z 622, 678, 734, and 789, respectively), diacylglycerol fragment ions (m/z = 
439, 495, 551, and 607, respectively), monoacylglycerol fragment ions (m/z = 257, 
285, 313, and 341, respectively), and fatty acids (m/z = 183, 211, 239, 267, 
respectively). However, high molecular weight ions (m/z >200), including many of the 
aforementioned fragment ions, usually have low intensities in the TOF-SIMS spectra 
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acquired from supported lipid membranes,14,16,24 though new primary ion sources 
may enhance the intensities of high mass fragment ions.37 Few characteristic mass 
peaks with m/z ≤200 are present in the spectra of the lipid standards due to their 
similar structures. 
 
 
Figure 3.1. The TOF-SIMS positive-ion spectrum and structures (inset) of four different saturated 
phosphatidylcholine species: (A) DLPC, (B) DMPC, (C) DPPC, and (D) DSPC.  The spectra were 
obtained from pure dried lipid films of these lipid using an ion dose of 2.4 × 1012 ions/cm2.   
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Figure 3.2. Scores and loadings plots from PCA of the TOF-SIMS positive-ion spectra of DLPC, 
DMPC, DPPC, and DSPC lipid films. These four saturated phosphatidylcholine species differ only in 
the lengths of their fatty acid tails. (A) The scores plot on PC1 and PC2 differentiates the four 
phosphatidylcholine lipid species. (B) The loadings plot illustrates the positive ion mass peaks that 
contribute to the variation captured by each PC.  PCA was performed on the ion peaks with m/z from 
30 to 200 amu, excluding the potassium (m/z = 39), calcium (m/z = 40), hydrocarbon impurity (m/z = 
41), chrome (m/z = 52) and PDMS contaminant (m/z = 73 and 147) peaks. These peaks were 
normalized to the total counts obtained over this mass range and mean-centered.  The ellipses in the 
score plot that are outlined with a solid line represent the border for each group at the 95% confidence 
limit.  The ellipse outlined with a dotted blue line represents the border for the entire PC model at the 
95% confidence limit.     
PCA was performed using the mass peaks with m/z from 30 to 200, excluding 
known contaminants, because these ions (m/z ≤200) are relatively abundant in the 
TOF-SIMS positive-ion spectra of lipid membranes.14,24 The resulting PC scores plot 
of the lipid spectra projected onto PC1 and PC2 (Figure 3.2A) demonstrates that 
these phosphatidylcholine species can be differentiated and classified.  The ellipse 
around each group in the scores plot shows the 95% confidence limit for the 
boundary of the group.38 The ellipse outlined with a dotted blue line represents the 
border for the entire PC model at the 95% confidence limit. The majority of the 
variation between lipid species is captured by PC1, which separates the lipids 
according to the lengths of their fatty acid tails.  The mass peaks responsible for this 
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lipid-specific separation have high loadings on PC1, and are shown in the loadings 
plot (Figure 3.2B). These values are partially tabulated in Table 3.1.  Both 
hydrocarbon and headgroup fragments have large loadings on PC1, indicating the 
normalized intensities of these ions vary significantly between the 
phosphatidylcholine species.  The hydrocarbon ions with m/z of 55 (C4H7+), 57 
(C4H9+), 67 (C5H7+), 69 (C5H9+), 71(C5H11+), 79 (C6H7+), 81 (C6H9+), and 83 
(C6H11+)29,39 have negative loadings on PC1 and therefore, relatively higher 
normalized intensities in the spectra from DSPC and DPPC. Headgroup fragments 
with m/z of 58 (C3H8N+), 59 (C3H9N+), 86 (C5H12N+), 102 (C5H12NO+), 104 
(C5H14NO+), 166 (C5H13NPO3+), and 184 (C5H15NPO4+),10,29,40 and the dodecanoic 
acid fragment at m/z = 183 load positively on PC1, and thus, have relatively higher 
normalized intensities in the spectra of DMPC and DLPC. Although all four lipid 
species have the same phosphocholine headgroup, the headgroup ions have a 
relatively higher normalized intensity in the spectra of DLPC and DMPC, likely 
because DLPC and DMPC have shorter fatty acid tails that contribute fewer 
hydrocarbon ions to their spectra.  On PC2, the loadings for the mass peaks that 
correspond to lipid headgroups (m/z = 184, 166, 104, 86, and 58) are negative, and 
the small hydrocarbon ion at m/z = 43 has a large positive loading.  PC2 may 
separate the samples according to disparities in their surface coverage, as opposed 
to lipid-specific chemical variations, because the intensities of the higher mass 
fragment ions and low mass hydrocarbon ions are influenced by surface coverage to 
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differing degrees.9 This ability to discriminate the lipid spectra according to the 
relative intensities of their low mass ions suggests that PCA of TOF-SIMS images 
might enable discriminating and imaging saturated phosphatidylcholine species 
within phase-separated lipid membranes. 
Table 3.1. Information on select peaks in the TOF-SIMS positive ion spectra of DLPC, DMPC, DPPC, 
and DSPC. 
m/z  Assignment10,29,39,40 Comments Loadings on PC1 
30 CH4N+ or C2H6+ Headgroup or hydrocarbon fragment 0.044 
43 C3H7+ or C2H2O+ Hydrocarbon chain or fatty acid fragment 0.181 
55 C4H7+ Hydrocarbon chain fragment -0.251 
57 C4H9+ Hydrocarbon chain fragment -0.293 
58 C3H8N+ Headgroup fragment 0.452 
59 C3H9N+ Headgroup fragment 0.127 
67 C5H7+ Hydrocarbon chain fragment -0.243 
 69 C5H9+ Hydrocarbon chain fragment -0.366 
71 C5H11+ Hydrocarbon chain fragment -0.122 
72 C4H10N+ Headgroup fragment 0.010 
74 C4H12N+ Headgroup fragment 0.044 
79 C6H7+ Hydrocarbon chain fragment -0.112 
81 C6H9+ Hydrocarbon chain fragment -0.145 
83 C6H11+ Hydrocarbon chain fragment -0.163 
86 C5H12N+ Headgroup fragment 0.409 
95 C7H11+ Hydrocarbon chain fragment -0.059 
97 C7H13+ Hydrocarbon chain fragment -0.054 
102 C5H12NO+ Choline 0.058 
104 C5H14NO+ Choline 0.146 
150 C5H13NPO2+ Headgroup fragment 0.022 
166 C5H13NPO3+ Headgroup fragment 0.022 
183 C12H23O+ Dodecanoic acid fragment 0.024 
184 C5H15NPO4+ Phosphocholine 0.006 
 
PCA of TOF-SIMS images of phase-separated supported lipid membranes 
Typically, TOF-SIMS analysis is performed using an ion dose below 1013 
ions/cm2 to prevent exceeding the static limit.29,41 However, our initial studies 
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demonstrated that analysis within the static limit yielded insufficient counts to 
visualize the lipid domains with PCA (Figure 3.3). Instead, we obtained higher ion 
counts, and better contrast and sensitivity in the resulting PC scores, images by 
slightly exceeding the static limit. Therefore, we used an ion dose of 2.8 × 1013 
ions/cm2 to image the phase-separated lipid membranes.  To further improve the 
image quality, the TOF-SIMS images were downbinned to 128 pixels x 128 pixels. 
Figure 3.4 shows select TOF-SIMS ion images of a DSPC/DLPC membrane (1:2 
molar ratio). For comparison, the AFM image acquired at the same membrane 
location prior to TOF-SIMS analysis is shown in Figure 3.6A. In the AFM image, the 
DSPC-rich gel-phase domains have diameters between 5 to 25 microns (light gray 
regions, Figure 3.6A), and protrude ~1.5 nm above the surrounding DLPC-rich fluid-
phase membrane regions (dark gray areas, Figure 3.6A). This height difference is 
slightly smaller than that previously measured between gel- and fluid-phase domains 
in DSPC/DLPC membranes,18,21,42 which may be due to our use of a repulsive tip-
sample interaction for AFM imaging.18,43,44 Submicron-size fluid-phase sub-domains 
were also detected by AFM within the gel-phase domains.  
Comparison between the AFM and TOF-SIMS ion images of the same 
membrane location indicates the hydrocarbon fragments with m/z of 43 (C3H7+), 57 
(C4H9+), 67 (C5H7+), 69 (C5H9+), and 83 (C6H11+) have higher counts (Figure 3.4) and 
normalized intensities (Figure 3.5) on the gel-phase DSPC-rich domains. In contrast, 
the ions with m/z of 58 (C3H8N+) and 183 (C12H23O+) have higher counts (Figure 3.4) 
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Figure 3.3. (A) AFM image shows the morphologies of the DSPC-enriched gel-phase domains, and 
the surrounding DLPC-enriched fluid-phase regions in the DSPC/DLPC (1:2 molar ratio) phase-
separated membrane. The PC1 (B) and PC2 (D) scores images were created by PCA of the TOF-
SIMS spectra that was acquired using an ion dose of 4 x 1012 ions/cm2 at the same membrane 
location as that shown in (A).  Phase separation is barely discernable in these PC scores images. For 
both PC1 and PC2, the gel-phase domains have positive scores (yellow), and the fluid-phase locations 
have negative scores (cyan). Loadings on PC1 (C) and PC2 (E) show the mass peaks with the largest 
variability between the gel- and fluid-phase membrane regions. Mass peaks with positive loadings 
have higher normalized intensities on the DSPC-rich gel-phase regions, and peaks with negative 
loadings have higher normalized intensities on the DLPC-rich fluid-phase domains.  
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Figure 3.4. Select TOF-SIMS positive ion images acquired on phase-separated supported lipid 
membranes composed of DSPC/DLPC (1:2 molar ratio) show the intensity of the specified mass peak.  
The images were obtained in unbunched mode for optimal lateral resolution.  The TOF-SIMS images 
were acquired of an 85 µm × 85 µm area with 256 x 256 pixels, downbinned to 128 pixels x 128 pixels, 
and cropped to show a 65 µm × 65 µm area of the membrane.  
 
 
Figure 3.5. Downbinned (128 pixels x 128 pixels) TOF-SIMS images showing the counts of the 
indicated mass peak normalized to the total ion counts at the same region of the phase-separated 
DSPC/DLPC (1:2 molar ratio) membrane shown in Figure 3.4.  
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and normalized intensities (Figure 3.5) on the fluid-phase DLPC-rich regions.  These 
observations are fairly consistent with the PC1 loadings calculated for the TOF-SIMS 
data from the pure lipid films (Figure 3.2).  Although the PC model of the pure lipid 
films indicates the relative normalized intensity of the phosphocholine ion (m/z = 184) 
is higher on DLPC, the contrast in the m/z = 184 ion image is too low to identify the 
phase-separated membrane domains. PCA of the TOF-SIMS images yielded PC 
scores images that graphically show the score value at every pixel in the TOF-SIMS 
image (Figure 3.6B). Comparison of the PC1 scores image to the AFM image 
acquired at the same location (Figure 3.6A) confirms that the PC1 scores image 
reveals phase separation in the membrane. The fluid-phase regions that are enriched 
with DLPC have positive scores (green, yellow, and red areas), and the gel-phase 
domains that are enriched with DSPC have negative scores (blue regions).  The 
contrast values for the PC1 scores image (Figure 3.6B) and the individual TOF-SIMS 
ion images (Figure 3.4) were calculated as previously reported,30,45 and are tabulated 
in Table 3.2. The higher contrast values of the PC scores image confirms that the 
PC1 scores image reveals the phase-separated lipid domains with better contrast 
than that obtained in the individual TOF-SIMS ion images. Therefore, although PC1 
accounts for only 2.4% of the pixel-to-pixel variation in the normalized TOF-SIMS 
peak intensities, this variation is significant.  The improvement in the sensitivity and 
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Figure 3.6.  (A) AFM image shows gel- and fluid-phase domains that are enriched with DSPC and 
DLPC, respectively, in the DSPC/DLPC (1:2 molar ratio) membrane. (B) The PC1 scores images 
generated by PCA of the downbinned TOF-SIMS image of the same membrane location.  The gel-
phase domains have negative scores (blue), and the fluid-phase locations have positive scores 
(green, yellow, and red). (C) The loadings on PC1 show the mass peaks with the largest variability 
between the gel- and fluid-phase regions of the membrane. The mass peaks with positive loadings 
have higher normalized intensities on the fluid-phase DLPC-rich regions, and the peaks with negative 
loading have elevated normalized intensities on the gel-phase DSPC-rich domains.  
specificity of lipid detection obtained with PCA is further demonstrated by the 
detection of the ~5-μm-wide gel-phase domain at the top right corner of the AFM and 
PC1 scores images (Figure 3.6A and B), as this domain was not visible in any of the 
individual TOF-SIMS ion images (Figure 3.4).  However, the submicron-size fluid-
phase subdomains entrapped within the large gel-phase domains that are shown in 
the AFM image (Figure 3.6A) were not resolved in the PC1 scores image. These 
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domains were also not detectable in the PC scores images produced by PCA of the 
unbinned (256 pixels x 256 pixels) TOF-SIMS data (Figure 3.7), which indicates 
these features were smaller than the lateral resolution of the TOF-SIMS analysis. 
Table 3.2. Contrast calculated for the individual TOF-SIMS ion images (Figure 3.4) and PC scores 
image (Figure 3.6B) of the same region of a phase-separated DSPC/DLPC membrane.  
Image Contrast 
m/z 43 1.13 
m/z 57 1.10 
m/z 58 0.45 
m/z 67 1.00 
m/z 69 1.23 
m/z 83 0.90 
m/z 183 0.40 
m/z 184 0.18 
PC1 1.97 
 
 
 
Figure 3.7. (A) PC1 scores image of the unbinned (256 pixels x 256 pixels) TOF-SIMS images 
acquired from the same location of a phase-separated DSPC/DLPC membrane as shown in Figure 3.6 
(contrast = 1.31). (B) Loadings on PC1 show the mass peaks with the largest variability on PC1. 
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The plot of the loadings on PC1 (Figure 3.6) shows which mass peaks have 
large positive loadings and, therefore, higher normalized intensities on the fluid-
phase DLPC-rich areas, and the peaks with large negative loadings and thus, higher 
normalized intensities on the gel-phase DSPC-rich domains. Many of the mass peaks 
that correspond to DSPC and DLPC according to the PC model developed on the 
pure lipid films are correlated with the DSPC-rich gel-phase and DLPC-rich fluid-
phase domains, respectively, based on the PC1 loadings for the PC model of the 
phase-separated membrane. This agreement suggests PC1 separates the spectra 
according to differences in lipid composition, and not variations in lipid packing or 
topography. Furthermore, sample topography is not a likely source of the spectral 
variation captured by PC1 because the loadings for the phase-separated membrane 
have both positive and negative values, and topographic effects in TOF-SIMS images 
are often isolated on a single PC that primarily loads in a single direction.27   
We investigated the generality of PCA of TOF-SIMS spectra to discriminate 
and image different saturated phosphatidylcholine species by applying this approach 
to phase-separated DPPC/DLPC (1:2 molar ratio) membranes. Unlike the individual 
TOF-SIMS ion images of the DSPC/DLPC membrane (Figure 3.4), the domains are 
barely discernable in the TOF-SIMS images of the counts and normalized intensities 
of specific ions acquired from the DPPC/DLPC membrane (Figures 3.8 and 3.9). For 
comparison, the AFM image acquired at the same location prior to TOF-SIMS 
analysis (Figure 3.10A) shows gel-phase domains that are several microns in 
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diameter and protrude ~1 nm above the surrounding fluid phase. This height 
difference is slightly smaller than that previously reported (1.4 nm),46 which, as stated 
above, is likely due to our use of a repulsive tip-sample interaction for AFM 
imaging.18,43,44 Submicron-size gel-phase domains are also visible within the fluid 
phase.  
 
Figure 3.8. Select TOF-SIMS positive-ion images acquired on phase-separated supported lipid 
membranes composed of DPPC/DLPC (1:2 molar ratio) show the intensity of the specified mass peak.  
The images were obtained in unbunched mode for optimal lateral resolution.  The TOF-SIMS images 
were acquired of a 65 µm × 65 µm area with 256 pixels x 256 pixels, downbinned to 128 pixels x 128 
pixels, and cropped to show a 60 µm × 60 µm region of interest. Phase-separated domains are barely 
visible in these images. 
 
The PC1 scores image (Figure 3.10B) clearly shows distinct regions that 
correlate with the gel- and fluid-phase domains detected with AFM (Figure 3.10A). 
Calculation of the contrast values, which are listed in Table 3.3, confirms that the 
contrast between the compositionally distinct gel- and fluid-phase domains is higher 
in the PC1 scores image than the individual TOF-SIMS ion images that are shown in 
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Figure 3.8.  Again, the submicron-size gel-phase domains that are visible in the AFM 
image (Figure 3.10A) were not resolved in either the downbinned and unbinned PC1 
scores images (Figure 3.10B and 3.11, respectively), indicating these domains are 
likely smaller than the lateral resolution of the TOF-SIMS analysis.  The plot of the 
PC1 loadings shows the mass peaks that have negative loadings, and therefore, 
higher normalized intensities on the gel-phase DPPC-rich domains, and the peaks 
with positive loadings and thus, higher normalized intensities on the fluid-phase 
DLPC-rich domains (Figure 3.10C). Again the presence of both positive and negative 
loadings on PC1 indicates topography is not likely responsible for the spectral 
variation captured by PC1. 
 
Figure 3.9. Downbinned (128 pixels x 128 pixels) TOF-SIMS images show the counts of the indicated 
mass peak normalized to the total ion counts at the same region of the phase-separated DPPC/DLPC 
(1:2 molar ratio) membrane shown in Figure 3.8.  
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Figure 3.10. (A) AFM image shows the morphologies of the DPPC-enriched gel-phase domains, and 
the surrounding DLPC-enriched fluid-phase regions in the DPPC/DLPC (1:2 molar ratio) phase-
separated membrane. (B) PC1 scores image created by PCA of the downbinned TOF-SIMS data of 
the same membrane location as (A).  The gel-phase domains have negative scores (blue), and the 
fluid-phase locations have positive scores (green, yellow and red). (C) Loadings on PC1 show the 
mass peaks with the largest variability between the gel- and fluid-phase membrane regions. Mass 
peaks with negative loadings have higher normalized intensities on the DPPC-rich gel-phase regions, 
and positives loadings have higher normalized intensities on the DLPC-rich fluid-phase domains.  
Table 3.3. Contrast calculated for the individual TOF-SIMS ion images (Figure 3.8) and PC scores 
image (Figure 3.10B) of the same region of a phase-separated DPPC/DLPC membrane. 
Image Contrast 
m/z 43 0.66 
m/z 57 0.55 
m/z 58 0.28 
m/z 67 0.55 
m/z 69 0.64 
m/z 83 0.43 
m/z 183 0.26 
m/z 184 0.04 
PC1 1.31 
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Figure 3.11. PCA of the unbinned (256 pixels x 256 pixels) TOF-SIMS images acquired from the 
same location of a phase-separated DPPC/DLPC membrane as shown in Figure 3.10A. (A) Phase 
separation is not visible in the PC1 scores image. The contrast calculated between the DLPC-rich 
fluid-phase domains and the DPPC-rich gel-phase domains in the PC1 scores image is 0.24. (B) 
Loadings on PC1 show the mass peak with the largest variability on PC1 is the small hydrocarbon 
fragment at m/z 43. Most of the other mass peaks load negatively on PC1. (C) PC2 scores image of 
the same membrane location reveals phase separation in the membrane (contrast = 0.68). (D) 
Loadings on PC2 show the mass peaks responsible for this contrast. 
 
Determination of lipid composition within distinct membrane domains by projection 
onto the PC model of lipid standards 
To identify the lipid composition within the gel- and fluid-phase domains 
(Figure 3.6B and 3.10B), we projected the TOF-SIMS data that we extracted from 
regions corresponding to gel- or fluid-phase domains in the DSPC/DLPC and 
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DPPC/DLPC membranes onto the PC model developed using the DLPC, DMPC, 
DPPC, and DSPC spectra, which was shown in Figure 3.2.  The resulting PC scores 
plot is shown in Figure 3.12. The PC1 scores for the TOF-SIMS spectra acquired 
from the DSPC/DLPC membrane designate that the gel-phase domains correspond 
to DSPC, in agreement with phase diagrams and previous reports.18,21,35,36 The fluid-
phase regions had scores on PC1 that were most similar to DMPC, followed by 
DLPC. Because these are model membranes with known composition, we conclude 
that the fluid-phase domains were enriched with DLPC, and not DMPC. We suggest 
the lower scores on PC1 may be due to the presence of tiny gel-phase domains in 
the fluid-phase. The scores on PC1 for the spectra acquired on the DPPC/DLPC 
membrane indicate that the gel-phase domains are composed of DPPC, as expected 
from the phase diagrams for this lipid mixture.18,21,35,36 The fluid-phase regions of the 
DPPC/DLPC membrane had PC1 scores that were consistent both DLPC and 
DMPC. Again, because the sample did not contain DMPC, we conclude that the fluid-
phase membrane regions were enriched with DLPC.  We speculate that tiny gel-
phase domains were present within the fluid-phase regions that had lower scores on 
PC1. The agreement between the compositions we determined by projecting onto PC 
models developed using lipid standards and previous reports18,21,35,36 suggests the 
chemical variations identified in the PC scores images were not due to the presence 
of the small amount (1 mol%) of fluorophore-labeled lipid in the fluid phase or 
difference in lipid packing between the two phases. We note that the spectra from the 
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lipid membranes had large residuals on the PC model of the lipid standards, 
indicating the lipid membranes were not well described by this PC model.  This 
imperfect fit may be due to differences in the surface coverage, lipid orientation, or 
ion dose used to analyze the lipid standards and membranes, and suggests these 
conditions should be keep constant to optimize the fit. Nonetheless, these results 
demonstrate that the lipid composition within distinct membrane domains can be 
identified through the use of PC models developed using spectra from lipid 
standards. 
 
Figure 3.12. Projection of the TOF-SIMS data extracted from gel- and fluid-phase regions of the 
DSPC/DLPC and DPPC/DLPC membranes onto the PC scores plot developed using the positive-ion 
spectra of the four phosphatidylcholine species: DLPC, DMPC, DPPC, and DSPC. The PC1 scores of 
the TOF-SIMS data extracted from the phase-separated membranes identifies the lipid composition at 
these sites. 
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Conclusions 
The distributions of saturated phosphatidylcholine species within phase-
separated lipid membranes can be differentiated and visualized by slightly exceeding 
the static limit of TOF-SIMS analysis, and using PCA to interpret the TOF-SIMS 
images.  Projection of the TOF-SIMS data from phase-separated domains onto PC 
models of pure lipid samples enables the identification of the lipid composition within 
subregions of the membrane.  This method can be used to image and identify the 
lipid composition at small areas within label-free model membranes composed of less 
well-characterized lipid mixtures.  The development of PC models constructed using 
the spectra from additional lipid species and cholesterol may also allow the 
discrimination and chemical imaging of structurally similar lipids within more complex 
membranes.  Further improvements in TOF-SIMS imaging and multivariate analysis 
approaches may also permit the detection of submicron-sized membrane domains.  
 
Materials and Methods 
Preparation of thin films of pure phosphatidylcholine lipids  
DLPC, DMPC, DPPC, and DSPC were purchased in chloroform from Avanti 
Polar Lipids (Alabaster, AL) and used without further purification.  A thin film of each 
lipid standard was created by spotting a small droplet of the lipid dissolved in 
chloroform onto a 5 mm x 5 mm silicon substrate that was patterned with a chrome 
grid to facilitate sample positioning.21 For each lipid standard, three different samples 
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were prepared on different days.  The sample was subjected to vacuum for a 
minimum of 3 h to evaporate the solvent. 
 
Preparation of phase-separated supported lipid membranes 
The lipid mixtures used to create phase-separated supported lipid membranes 
consisted of a 1:2 molar ratio of DSPC/DLPC or DPPC/DLPC, plus 1 mol% of the 
fluorescent lipid, 1-palmitoyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]lauroyl}-
sn-glycero 3-phosphocholine (NBD-PC, Avanti Polar Lipids, Alabaster, AL) for 
visualization with fluorescence microscopy.  Small unilamellar vesicles (SUVs) 
composed of DSPC/DLPC/NBD-PC were prepared by tip sonification (Branson Tip 
Sonifier Model 250D, Branson Ultrasonics, Danbury, CT).18,42 SUVs composed of 
DPPC/DLPC/NBD-PC were made with an extruder19,21,42 because this method 
produced larger phase-separated domains.  Supported lipid membranes were formed 
by slow-cooled vesicle fusion onto the silicon substrates described above.18,21 42 The 
DSPC/DLPC and DPPC/DLPC bilayers were annealed at 70 °C and 55 °C, 
respectively, for 1 h, and then were slowly cooled at a rate of 2.6°C/hr and 1.5°C/hr, 
respectively, to induce phase-separation. 
To permit analyzing the samples with TOF-SIMS, which is performed under 
ultra-high vacuum (UHV), the samples were flash-frozen in liquid ethane, and then 
the ice was sublimed from the membrane using an oil-free scroll pump (Triscroll 300, 
Varian, Inc. Palo Alto, CA).21 Fluorescence microscopy (Leica DM6000 B, Q-Imaging 
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EXi Blue Fluorescence Microscope) was used to evaluate membrane quality, and to 
generate optical maps of the samples that enabled imaging the same sample 
locations with both AFM and TOF-SIMS.  
 
AFM analysis of phase-separated lipid membranes 
The freeze-dried supported lipid membranes were imaged with an Asylum 
MFP-3D™ Stand Alone AFM (Asylum Research, Santa Barbara, CA) in ambient air 
and temperature.  Measurements were taken in AC mode (tapping) in the repulsive 
tip-sample interaction regime with standard 300 kHz AFM probes (Tap300Al-G, 
Budget Sensors, Bulgeria). AFM images were flattened to the second-order, and line 
scans between the gel- and surrounding fluid-phase domains were made to verify 
that symmetric phase-separated domains were present.   
 
TOF-SIMS analysis 
 TOF-SIMS analysis was performed on a PHI Trift-III TOF-SIMS (Physical 
Electronics Incorporated, Chanhassen, MN) using a gold liquid ion gun operated at 
22 kV. A 197Au+ primary ion beam with 3.7 nA and 1 nA was used to analyze the lipid 
films and phase-separated lipid membranes, respectively.  TOF-SIMS data from the 
lipid films were acquired from 100 µm × 100 µm sample regions using bunched 
mode. TOF-SIMS spectra were acquired at twelve different regions on each pure lipid 
film.   
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TOF-SIMS analysis of the phase-separated supported lipid membranes was 
performed in unbunched mode for optimal lateral resolution. TOF-SIMS images with 
256 pixels x 256 pixels were acquired from 85 µm × 85 µm or 65 µm × 65 µm areas 
on the membrane, and were cropped to show subregions of the membrane.  TOF-
SIMS spectra were obtained with a mass range of 0 to 800 amu and a mass 
resolution of M/ΔM = 850 at the C3H7+ peak (m/z 43).  The analysis time varied 
according to the size of the acquisition area in order to keep a constant primary ion 
dose of 2.4 × 1012 ions/cm2 for the pure lipid films, and 2.8 × 1013 ions/cm2 for the 
phase-separated supported lipid membranes. To improve the image quality, 
downbinned TOF-SIMS images were created by summing the intensities of the mass 
peaks over 2 pixels x 2 pixels, producing individual TOF-SIMS ion images with 128 
pixels x 128 pixels. 
  
PCA of TOF-SIMS spectra of pure lipid films and phase-separated lipid membranes 
PCA was performed using the PLS Toolbox and the MIA Toolbox (v.5.2.2 and 
v.1.0.7, respectively, Eigenvector Research, Manson, WA), which were run in 
MATLAB (v.7.8.0, MathWorks Inc., Natick, MA).  Unit mass binning was applied to 
each spectrum acquired from a pure lipid film. The mass peaks from m/z 30 to 200 
were used for analysis, but the peaks with m/z of 39 (potassium), 40 (calcium), 41 
(hydrocarbon contaminant), 52 (chrome grid), 73 (PDMS contaminant), and 147 
(PDMS contaminant) were removed from the spectra.47 The TOF-SIMS data was 
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arranged in a matrix such that the different samples formed the rows and the 
individual mass peaks formed the columns. Each mass spectrum of a pure lipid film 
was normalized to the total intensity of the selected peaks and mean-centered. A PC 
model was constructed using the mass spectra from the four different lipid species.  
Score plots were generated that illustrate the projection of the TOF-SIMS data from 
the phosphatidylcholine species onto the new PCs.  Loadings plots were created that 
exhibit the linear combination of mass peaks that contributed to each PC. Mass 
peaks with large positive or negative loadings on a PC tend to have relatively higher 
intensities in the normalized spectra of the samples with positive or negative scores, 
respectively, on the same PC.28 
For PCA of the TOF-SIMS images acquired on the phase-separated supported 
lipid membranes, the mass peaks with counts of at least 0.1% of the highest 
observed count rate were imported directly into the PLS toolbox.  The intensities of 
the mass peaks were summed over 2 pixels x 2 pixels, producing downbinned 
images with 128 x 128 pixels.  If the chrome grid that is used for sample positioning 
was visible in the TOF-SIMS image, PCA was performed only on the region of the 
image where the membrane was located.  As in the analysis of the lipid standards, 
the mass peaks listed above (m/z 0 to 29, 39, 40, 41, 52, 73, and 147) were removed 
from the spectra. The resulting spectra were normalized to the total intensity of the 
selected peaks and autoscaled. Finally a PC model was created that converted the 
TOF-SIMS data from n ion images of 128 pixels × 128 pixels, where n is the number 
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of mass peaks, into a two dimensional array with n columns and 16,384 rows that 
contained the TOF-SIMS data collected at every pixel.  A score value was calculated 
for each pixel, and the data was reassembled into a 128 pixel × 128 pixel image in 
which the score value at each pixel was encoded by a pseudo-color scale.  We refer 
to this graphic representation of the scores values as a PC scores image.  A loadings 
plot for each PC that shows the linear combination of mass peaks that contribute to 
the PC was generated.   
 
Calculation of image contrast 
To compare the quality of the individual TOF-SIMS images and PC scores 
images, contrast between the gel- and fluid-phase membrane domains within the 
images was calculated according to the following equation, as previously 
reported.30,45  
      
Where Igel is the average intensity in the gel-phase domains, Ifluid is the average 
intensity in the fluid-phase domains, and σ gel, fluid is the standard deviation of the 
intensity within both regions. Intensity refers to counts in the individual TOF-SIMS ion 
images, and to the PC score values in the PC scores images. 
 
Identification of lipid composition in the gel- and fluid-phase domains within phase-
separated membranes using PCA 
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TOF-SIMS data were extracted from 12 regions of interest (ROIs) on the gel- 
and fluid-phase membrane regions, which were identified by comparison to the AFM 
image of the DSPC/DLPC and DPPC/DLPC membranes (24 ROIs per membrane, 48 
ROIs in total). Unit mass binning was applied to each spectrum acquired from a ROI 
on the membrane.  For each of the resulting 48 TOF-SIMS spectra, the normalized 
peaks from m/z 30 to 200 that did not correspond to the impurity peaks listed above 
were loaded as the validation block in the PC model developed using the pure lipid 
films.  The mass spectra from the lipid membranes were arranged in a matrix as 
described above, normalized to the total intensity of the selected peaks each 
spectrum, mean-centered, and then projected onto the PC model developed using 
the pure lipid films. Although the spectra from the lipid standards were acquired with 
higher mass resolution than the TOF-SIMS images of the phase-separated lipid 
membranes, the mass resolution in the data set was ultimately limited by the unit 
mass binning applied to all the spectra prior to data processing.    
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Chapter 4.  
ENHANCING TOF-SIMS IMAGING OF LIPID MEMBRANES 
USING LIPID-RELATED PEAKS SETS AND PRINCIPAL 
COMPONENT ANALYSIS 
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Introduction 
Lateral heterogeneity in the component distribution within the cellular plasma 
membrane is widely believed to be vital for a variety of cell functions. The 
distributions of specific proteins can be visualized by using functionalized affinity 
labels or genetically encoded fluorescent protein constructs. Unfortunately, 
fluorophores can alter the molecular interactions and the distributions of the lipids 
that they label, so far fewer approaches are available for elucidating the organization 
of specific lipid species. To unambiguously identify the lipid distribution within cellular 
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or model membranes, spatially well-resolved chemical information is required. The 
distributions of different lipid classes within model membranes can be chemically 
imaged with as high as submicrometer lateral resolution by using time-of-flight 
secondary ion mass spectrometry (TOF-SIMS).1-3 However, discriminating between 
structurally similar, unlabeled lipid species within a TOF-SIMS image is very 
challenging. High mass fragment ions (i.e., molecular ions and large fragment ions) 
are often characteristic of a single lipid species, but typically have low yields that 
results in insufficient signal-to-noise ratios for chemical imaging with submicron 
lateral resolution.4,5 Lipids also produce low mass fragment ions (m/z < 200) that 
have higher yields and better signal-to-noise ratios, but these ions are often common 
to multiple lipid species, prohibiting unambiguous identification. 
Multivariate analysis techniques, such as principal component analysis (PCA), 
are statistical methods that can be used to distinguish various molecules according to 
combinations of numerous mass peaks that may be common to multiple samples.6-12 
Multivariate analysis of TOF-SIMS data has enabled discriminating and imaging 
structurally similar organic molecules, including monosaccharide isomers,12 
proteins,13-15 alkane thiols,7 and lipids.16-19 We recently demonstrated that unlabeled, 
saturated phosphatidylcholine lipids could be successfully discriminated by PCA of 
their TOF-SIMS spectra.19 PCA of the TOF-SIMS images allowed visualizing the 
distributions of saturated phosphatidylcholine species within phase-separated lipid 
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membranes with quantifiably higher contrast than that present in any of the individual 
TOF-SIMS ion images.19 
The ability of PCA to discriminate the TOF-SIMS data of structurally similar 
molecules is influenced by the number of mass peaks in the spectra that are not 
generated by the molecules of interest. If sample-to-sample variation in the spectra is 
dominated by mass peaks related to contaminants or the sample substrate, then the 
spectral variation associated with the molecules of interest can be difficult to detect 
using PCA.7 In addition, whether classification by PCA of TOF-SIMS data is truly 
based on chemical differences between the samples, as opposed to sample-related 
contamination, is a concern. However, these problems can be circumvented by 
performing PCA on a restricted data set that contains only the mass peaks that are 
related to the molecules of interest.7,15 For example, PCA of proteins is often 
performed using a restricted data set that consists of mass peaks associated with 
amino acids.13,14,16,20-22 Consequently, the establishment of a restricted set of mass 
peaks that are associated with lipids could improve the identification of various lipid 
species in the TOF-SIMS images acquired from model membranes, and facilitate 
identifying the origins of mass peaks acquired from native cell membranes.  
In this chapter, we identify the TOF-SIMS peaks that are associated with 
phosphatidylcholine lipids by using PCA to detect the peaks that differentiate an 
isotope-substituted lipid from the analogous unlabeled, natural abundance molecule. 
Because the lipid isotopologues are chemically identical and differ only in isotope 
89 
composition, the characteristic mass shift between ions containing different isotopes 
can be used to confirm the isotopologue-associated peaks are lipid fragments, and 
not ions produced by sample-specific contaminants. To identify the peaks associated 
with the lipid headgroup, we used PCA to characterize the spectral differences 
between natural abundance 1,2-dilauroyl-sn-glycero-3-phosphocholine (DLPC) and 
15N-DLPC. The mass peaks related to the lipid tails were discriminated according to 
the spectral differences between natural abundance 1,2-distearoyl-sn-glycero-3-
phosphocholine (DSPC) and a DSPC isotopologue with perdeuterated fatty acid tails 
(D70-DSPC). We use the Fisherʼs ratio, which is a quantitative measure of the 
discrimination between groups on each multivariate axis,15,23 to assess how use of 
the restricted set of mass peaks influences the classification of standard lipid 
samples by PCA. We also evaluated how use of these lipid-related peak sets 
influences visualization of lipid distribution within phase-separated lipid membranes.  
 
Figure 4.1. Positive-ion spectra and structures (inset) of DLPC isotopologues: (A) DLPC and (B) 15N-
DLPC. The spectra were obtained using an ion dose of 9.7 x 1011 ions/cm2.  
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Results and Discussion 
Identification of Mass Peaks Related to Lipid Headgroups 
The mass spectra acquired from unlabeled, natural abundance DLPC and 15N-
DLPC are shown in Figure 4.1. To detect the headgroup-related differences in the 
spectra from the DLPC isotopologues, PCA was performed on the 12 TOF-SIMS data 
sets acquired from each lipid (Figure 4.2). Each TOF-SIMS data set consisted of the 
mass peaks in the 1-300 m/z range, with the exception of known inorganic ions (Li+, 
Na+, Si+, and K+). This mass range was selected because secondary ions with m/z > 
300 usually have intensities that are too low to be utilized for TOF-SIMS imaging of 
lipid membranes with submicron-scale lateral resolution.5,17 Figure 4.2A shows the 
scores on PC1 and PC2 from PCA of 12 TOF-SIMS data sets acquired from 15N-
DLPC and natural abundance DLPC. PC1 captures the majority of variance in the 
data (90.9%), and separates the samples according to their isotope composition. 
PC2 captures a much smaller percentage of the variance in the data (5.5%) that is 
not related to the lipid isotope composition (see below).  
The mass peaks that contribute highly to differentiating the lipid spectra by 
isotope composition have high loadings on PC1, and are shown in the PC1 loadings 
plot in Figure 4.2B. Note that the fatty acid tails in 15N-DLPC and DLPC are 
chemically and isotopically identical, so the fatty acid fragment ions from the DLPC 
isotopologues should be identical, and, therefore, have negligible loadings on PC1.  
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Figure 4.2. Scores and loadings plots from PCA of the positive-ion spectra acquired from natural 
abundance DLPC and 15N-DLPC. These two lipid species differ only in the nitrogen isotope in the 
headgroup. PCA was performed on the peaks with m/z from 1 to 300 amu, excluding the lithium (m/z = 
7), sodium (m/z = 23), and potassium (m/z = 39) ions. The peaks were normalized to the total counts 
in the data set and mean-centered. (A) The scores on PC1 differentiate the lipids by their nitrogen 
isotope. The variance captured on PC2 is not isotope-specific. The ellipses outlined with solid and 
dashed lines represent the border for each group, and the whole model, respectively, at the 95% 
confidence limit. (B) The loadings plot shows the mass peaks that are responsible for the majority of 
the variance in the spectra of DLPC and 15N-DLPC. (C) Loadings plot shows the mass peaks that are 
responsible for the spectral variance captured on PC2. 
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Table 4.1. Headgroup-related mass peaks and assignments identified by PCA of the positive ion 
spectra of DLPC isotopologues that were acquired with TOF-SIMS. 
 
m/z Proposed assignments 
DLPC/15N-DLPC DLPC/15N-DLPC 
30/31 CH4N+/CH415N+ 
44/45 C2H6N+/C2H615N+ 
56/57 C3H6N+/C3H615N+ 
58/59 C3H8N+/C3H815N+ 
59/60 C3H9N+/C3H915N+ 
60/61 C3H10N+/C3H1015N+ 
68/69 C4H6N+/C4H615N+ 
70/71 C4H8N+/C4H815N+ 
72/73 C4H10N+/C4H1015N+ 
74/75 C4H12N+/C4H1215N+ 
82/83 C5H8N+/C5H815N+ 
84/85 C5H10N+/C5H1015N+ 
86/87 C5H12N+/C5H1215N+ 
88/89 C5H14N+/C5H1415N+ 
98/99 C5H8NO+/C5H815NO+ 
100/101 C5H10NO+/C5H1015NO+ 
102/103 C5H12NO+/C5H1215NO+ 
104/105 C5H14NO+/C5H1415NO+ 
147/148 C5H10NPO2+/C5H1015NPO2+ 
148/149 C5H11NPO2+/C5H1115NPO2+ 
150/151 C5H13NPO2+/C5H1315NPO2+ 
166/167 C5H13NPO3+/C5H1315NPO3+ 
168/169 C5H15NPO3+/C5H1515NPO3+ 
182/183 C5H13NPO4+/C5H1315NPO4+ 
184/185 C5H15NPO4+/C5H1515NPO4+ 
190/191 C7H13NPO3+/C7H1315NPO3+ 
194/195 C7H17NPO3+/C7H1715NPO3+ 
196/197 C6H15NPO4+/C6H1515NPO4+ 
198/199 C6H17NPO4+/C6H1715NPO4+ 
206/207 C5H14NPO4Na+/C5H1415NPO4Na+ 
210/211 C7H17NPO4+/C6H1715NPO4+ 
212/213 C7H19NPO4+/C6H1915NPO4+ 
224/225 C7H15NPO5+/C7H1515NPO5+ 
226/227 C7H17NPO5+/C7H1715NPO5+ 
238/239 C8H17NPO5+/C6H1715NPO4+ 
240/241 C8H19NPO5+/C8H1915NPO4+ 
246/247 C8H18NPO4Na+/C8H1815NPO4Na+ 
or C8H18NPO5Li+/C8H1815NPO5Li+ 252/253 8 15 P 6+/C8H1515NPO6+ 
254/255 C8H17NPO6+/C8H1715NPO6+ 
256/257 C8H19NPO6+/C8H1915NPO6+ 
282/283 C9H17NPO7+/C9H1715NPO7+ 
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The mass peaks with positive loadings have higher relative intensities in the spectra 
of 15N-DLPC, and should include 15N-labeled lipid headgroup fragments. In contrast, 
the mass peaks with negative loadings have higher relative intensities in the spectra 
of natural abundance DLPC, and should include unlabeled lipid headgroup 
fragments. Sample-specific contaminants may also contribute to the variation 
between the spectra, and have high loadings on PC1. Therefore, we identified the 
peaks that correspond to lipid headgroup fragments according to the presence of a 1 
nominal mass that had higher intensity on the other DLPC isotopologues.  For 
instance, the C3H10N+ fragment at m/z 60, respectively, was masked by the C3H915N+ 
ion with the same molecular weight.  A few mass peaks with high loadings on PC1 
were associated with contaminants due to the absence of an oppositely loading peak 
with the characteristic 1-amu shift. These contaminant-related peaks include small 
hydrocarbons (m/z 15, 27, 29, and 41) and the silicon substrate (m/z 28). 
The loadings on PC2 are shown in Figure 4.2C. The peaks with high loadings 
on PC2 include ions related to the silicon substrate (m/z 28), hydrocarbon fragments 
(m/z 27, 29, 41, and 43), and polydimethylsiloxane (PDMS) contaminants (m/z 73, 
147, 207, 221, and 281).24 A few ions that are characteristic of lipid headgroup 
fragments (m/z 104, 166, 167, 184, and 185) are also present. Therefore, PC2 likely 
captures variance in the sample spectra that is related to the amount of lipid surface 
coverage and contamination on the substrate.  
 
94 
Identification of Mass Peaks Related to Lipid Fatty Acid Tail Groups  
Representative mass spectra for DSPC and D70-DSPC are shown in Figure 
4.3. These DSPC isotopologues have the longest fatty acid tails of any lipid 
frequently studied in model membranes. Therefore, their spectra should contain both 
the mass peaks from larger hydrocarbon ions that are related to lipids with long fatty 
acid tails, and the smaller hydrocarbon fragment ions that are generated by all lipid 
species. In addition, these hydrocarbon fragments will also reflect those produced by 
lipids with unsaturated fatty acid tails because fragmentation of the saturated alkyl 
moieties yields both alkyl and alkenyl carbocations.25 To detect the fatty acid-related 
mass peaks in the spectra, PCA was performed on the 12 positive-ion spectra 
acquired from each isotopologue with TOF-SIMS. Figure 4.4A shows the scores for 
each sample on PC1 and PC2. The vast majority of the variance in the data (99.9%) 
is captured by PC1, which separates the samples according to their isotope 
composition. In contrast, PC2 captured only a very small amount of the variation in 
the data (0.05%), and will not be discussed further. The mass peaks responsible for 
discriminating DSPC and D70-DSPC, and contributing to the variation on PC2 are 
shown in the PC1 and PC2 loadings plots in Figure 4.4B and C. The mass peaks with 
positive loadings on PC1 are characteristic of DSPC and are expected to include the 
natural abundance fatty acid fragments. In contrast, the mass peaks with negative 
loadings on PC1 have higher normalized intensities in the spectra of D70-DSPC, and 
are expected to correspond to perdeuterated fatty acid fragments. The isotopologue-
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associated peaks that corresponded to fatty acid tails were identified by the presence 
of oppositely loading mass peaks with the characteristic mass shift between fragment 
ions that differ in hydrogen isotope composition. In addition, examination of the 
individual mass spectra also indicated that the DSPC-related C2H6+ fragment at m/z 
42 was masked on PC1 by overlap with the D70-DSPC-related C2DO+ fragment with 
the same nominal mass. Table 4.2 lists the fatty acid-related peaks we identified. 
Note that PCA of DOPC and D70-DSPC spectra confirmed that these peaks are also 
related to the DOPC fatty acid fragments (Figure 4.5). This indicated that this peak 
set is applicable to both saturated and unsaturated lipids, and can be used to assess 
the spectra of a range of model and cellular membranes. 
 
Figure 4.3. Positive-ion spectra and structures (inset) of DSPC isotopologues: (A) DSPC and (B) D70-
DSPC. The spectra were obtained using an ion dose of 9.7 x 1011 ions/cm2.  
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Figure 4.4. Scores and loadings plots from PCA of the spectra of natural abundance DSPC and D70-
DSPC. The protons within the fatty acid tails are completely substituted with deuterium in D70-DSPC. 
PCA was performed on the peaks in the 1-300 m/z range, excluding the lithium (m/z = 7), sodium (m/z 
= 23), and potassium (m/z = 39) ions. The peaks were normalized to the total counts in the data set 
and mean-centered.  (A) The scores on PC1 differentiate the lipids by isotope composition. PC2 
captures a very small amount of spectral variance (<<1%), which is not isotope-specific. The ellipses 
outlined with solid and dashed lines represent the border for each lipid, and the whole model, 
respectively, at the 95% confidence limit.  (B) The loadings plot shows the mass peaks that 
discriminate the spectra of DSPC and D70-DSPC. (C) Loadings plot shows the mass peaks that are 
responsible for the spectral variance captured on PC2. 
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Table 4.2. Fatty acid tail-related mass peaks and assignments identified by PCA of the positive ion 
TOF-SIMS data acquired from DSPC and D70-DSPC. 
 
m/z 
DSPC/D70DSPC 
Proposed assignments 
DSPC/D70DSPC 
15/18 CH3+/ CD3+ 
27/30 C2H3+/C2D3+ 
29/34 C2H5+ / C2D5+ 
41/46 C3H7+ / C3D7+ 
41/42 C2HO/C2DO 
42/46 C3H6+ / C3D6+ 
43/50 C3H7+ / C3D7+ 
53/58 C4H5+/ C4D5+ 
54/60 C4H6+/ C4D6+ 
55/62 C4H7+/ C4D7+ 
57/66 C4H9+/ C4D9+ 
67/74 C5H7+/ C5D7+ 
69/78 C5H9+/ C5D9+ 
71/82 C5H11+/ C5D11+ 
81/90 C6H9+/ C6D9+ 
83/94 C6H11+/ C6D11+ 
85/98 C6H13+/ C6D13+ 
91/98 C7H7+/C7D7+ 
93/102 C7H9+/C7D9+ 
95/106 C7H11+/ C7D11+ 
97/110 C7H13+/ C7D13+ 
111/126 C8H15+/ C8D15+ 
 
 
Figure 4.5. Scores and loadings plots from PCA of the positive-ion spectra acquired from DOPC and 
D70-DSPC (structures inset). DOPC differs from DSPC only in fatty-acid chain saturation. PCA was 
performed on the peaks with m/z from 1 to 300 amu, excluding the lithium (m/z = 7), sodium (m/z = 
23), and potassium (m/z = 39) ions. The peaks were normalized to the total counts in the data set and 
mean-centered. (A) The scores on PC1 differentiate the lipids by isotope composition. PC2 captures a 
very small amount of spectral variance (<<1%), which is not isotope-specific and is not shown here. 
(B) The loadings plot shows the mass peaks that discriminate the spectra of DOPC and D70-DSPC, 
which has very similar loadings to that of PCA of DSPC and D70-DSPC, illustrated in Figure 4.4B.  
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Classification of Lipid Standards 
 We evaluated how the use of the lipid-related mass peak set influences the 
discrimination between four unlabeled phosphatidylcholine lipid species: DLPC, 1,2-
dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 1,2-dipalmitoyl-sn-glycero-3-
phosphocholine (DPPC), and DSPC. The TOF-SIMS spectra of these 
phosphatidylcholine species are difficult to discriminate because each lipid contains 
two saturated fatty acid tails, a phosphocholine headgroup, and a glycerol backbone. 
PCA was performed using four different TOF-SIMS peak sets with m/z in the 1-300 
range that were acquired from DLPC, DMPC, DPPC, and DSPC (Table 4.3). A 
complete peak set that consisted of all mass peaks with m/z 1-300 except for m/z 7, 
23, 28, and 39 from Li+, Na+, Si+ and K+, respectively, was selected as the first peak 
set, as PCA is typically performed on a complete peak set in which only salt cations 
(Li+, Na+, and K+) and substrate ions are excluded. A contaminant-free peak set that 
consisted of all peaks with m/z 30-300 except for m/z 39 (K+), 40 (Ca+), 41 
(hydrocarbon), 52 (Cr+), 73 (PDMS), 147 (PDMS), 207 (PDMS), 221 (PDMS), and 
281 (PDMS) was used for the second peak set because very low mass peaks 
(m/z<30) that have poor molecular specificity,19,20,26 and peaks produced by known 
contaminants are often removed from TOF-SIMS data sets prior to PCA.9,12,19,20,26 
The third data set was a lipid-related peak set that consisted only of the ion peaks 
that are listed in Tables 4.1 and 4.2. The fourth peak set was a contaminant-free 
lipid-related peak set that consisted of the lipid-related peaks that are listed in Tables 
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4.1 and 4.2, but peaks with m/z<30 and those related to known contaminants (m/z 
39, 40, 41, 52, 73, 147, 207, 221, and 281) were excluded.  
 
Table 4.3. Description of the four peak sets that were constructed using the same TOF-SIMS data that 
was collected from DLPC, DMPC, DPPC, and DSPC. Each peak set consisted of the mass peaks with 
m/z 1-300, but different masses were excluded from each peak set. The Fisher's ratio (FR) calculated 
on PC1 is a quantitative measure of the lipid discrimination. 
 
Peak set (m/z 1 - 300) Excluded peaks FR 
Complete m/z 7, 23,28 and 39 6.6 
Contaminant-free m/z<30, 39, 40, 41, 52, 73, 147, 207, 221, 281 59 
Lipid-related Peaks not listed in Tables 4.1 and 4.2 14 
Lipid-related and 
contaminant-free 
Peaks not listed in Tables 4.1 and 4.2, and m/z<30, 41, 
147 55 
 
The scores and loadings plots produced by PCA of the four peak sets are 
shown in Figure 4.6. For all peak sets, the PC1 scores separate the lipids according 
to the length of their fatty acid tails, whereas the PC2 scores were not related to the 
lipid composition. We quantitatively assessed the lipid-specific discrimination of the 
different phosphatidylcholines by calculating the PC1 Fisherʼs ratio (Table 4.3).23 The 
lipid standards were not well-separated in the PC1 and PC2 scores plot (Figure 4.6A) 
by PCA utilizing the complete peak set, and the calculated PC1 Fisherʼs ratio (6.6) 
confirmed that the lipid-specific separation was low. The loadings plot for the 
complete peak set (Figure 4.6B) shows the masses that contribute significantly to the 
spectral variation captured by PC1 include m/z 27, 29, 41 and 43. Thus, the poor 
separation may have occurred because both lipid-related hydrocarbons and 
contaminants contributed to these peaks. Visual inspection of the PC1 and PC2 
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scores plot (Figure 4.6C) obtained by PCA of the contaminant-free peak set indicated 
excellent separation between the lipid standards. We calculated a Fisher's ratio of 59 
on PC1, verifying that significantly higher lipid-specific separation was achieved.  The 
PC1 and PC2 scores plot produced with the lipid-related peak set (Figure 4.6E) 
indicated that restriction of the data set to the lipid-related peaks produced better 
discrimination of the phosphatidylcholine species than that obtained with the 
complete data set, but poorer discrimination than that achieved using the 
contaminant-free peak set. This was confirmed by the PC1 Fisher's ratio we 
calculated for the lipid-related peak set, which was 14. The loadings plot for the lipid-
related peak set (Figure 4.6F) shows hydrocarbon ions related to both lipid fragments 
and contaminants (m/z 27, 29, and 41) had high loadings on PC1, which likely 
compromised lipid separation. Lipid separation on PC1 and PC2 (Figure 4.6G) could 
be improved by removing the very low mass peaks (m/z<30) and those related to 
contaminants from the lipid-related peak set. A PC1 Fisher's ratio of 55 was 
calculated for the contaminant-free lipid-related peak set, indicating the lipid-specific 
discrimination was similar to that obtained using the contaminant-free peak set. The 
loadings plot from PCA of the contaminant-free lipid-related peak set (Figure 4.6H) 
also appeared to be similar to the loadings plot from PCA of the contaminant-free 
peak set (Figure 4.6D). 
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Figure 4.6. Scores and loadings plots on PC1 and PC2 from PCA of different sets of mass peaks in 
the spectra acquired from DLPC, DMPC, DPPC, and DSPC lipid films. Scores (A) and loadings plots 
(B) produced by PCA of the data sets consisting of all mass peaks with m/z 1-300 except for the 
known inorganic ions (Li, Na, Si, and K). Scores (C) and loadings plots (D) from PCA of TOF-SIMS 
data sets that consisted of the peaks with m/z 30-300 with the exclusion of known contaminants ions 
(m/z 39, 40, 41, 52, 73, 147, 207, 221, and 281). Scores (E) and loadings plots (F) from PCA of 
restricted TOF-SIMS data sets that contained only the mass peaks related to the lipid headgroups 
(Table 4.1) and fatty acid tails (Table 4.2). Scores (G) and loadings (H) plots from PCA of the 
restricted TOF-SIMS data sets containing only the lipid-related peaks with the exclusion of peaks with 
m/z > 30 and those of known contaminant ions (m/z 39, 40, 41, 52, 73, 147, 207, 221, and 281). 
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Scores Images of Phase-Separated Supported Lipid Membranes 
 We evaluated how the use of the restricted mass peak set influenced 
visualization of the lipid distribution within phase-separated lipid membranes by PCA 
of the TOF-SIMS images. Figure 4.7 shows the AFM image that was acquired from a 
phase-separated DSPC/DLPC supported lipid membrane prior to TOF-SIMS 
analysis. Here, we see phase separation between the DSPC enriched gel-phase 
domains, which are the taller features, and the surrounding DLPC enriched fluid-
phase region, which are the shorter areas.19,27,28 PCA was performed on the TOF-
SIMS analysis of this same membrane region using the peak sets noted in Table 4.3, 
and Figure 4.8 shows the resulting PC scores images and loadings plots. 
 
Figure 4.7. AFM image of a phase-separated DSPC/DLPC membrane. The image shows gel- and 
fluid-phase domains that are enriched with DSPC and DLPC, respectively, in the DSPC/DLPC (1:2 
molar ratio) membrane. 
 
In the complete data set PCA analysis (Figure 4.8A and B), the phase-
separation between the two chemically distinct membrane regions is reveled. The 
contrast between these two regions was calculated as described in Chapter 3,19 and 
was determined to be 1.74. The very low mass peaks (m/z<30) that have poor  
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Figure 4.8. PCA of a TOF-SIMS image taken at the same location of the phase-separated 
DSPC/DLPC membrane shown in Figure 6. Scores images resulting from PCA of the (A) complete 
peak set, (C) contaminant-free peak set, (E) lipid-related peak set, and (G) lipid-related and 
contaminant-free peak set (refer to Table 4.3). The loadings plots for the (B) complete peak set, (D) 
contaminant-free peak set, (F) lipid-related peak set, and (H) lipid-related and contaminant-free peak 
set show the extent that each peak contributed to the spectral variation captured by PC1. 
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molecular specificity,19,20,26 were removed in the contaminant-free analysis (Figure 4C 
and D), and the contrast between the DSPC and DLPC enriched membrane regions 
was determined to be 1.53, which is less than the complete peak set analysis. In the 
third analysis only the lipid-related peaks were included (Figure 4.8E and F), and the 
contrast between the gel- and fluid-phase domain was calculated to be 1.57, which is 
better than the contaminant-free analysis, but poorer than the complete data set 
analysis. Finally, the contaminant-free lipid-related peaks were used for PCA (Figure 
4.8G and H), and the contrast value for this image (1.34) was the poorest of all four 
analyses. From this analysis it was established that the complete data set had 
quantifiably the greatest contrast. However, by sacrificing less than 10% of the 
contrast, and using only the lipid-related peaks, one can be more confident PCA 
separation is based on the DSPC and DLPC content, as opposed to non-specific 
fragments that could be contaminants, such as m/z= 73 (PDMS), which significantly 
contributes to the contrast in the complete data set (Figure 4.8B). 
 
Figure 4.9. AFM image of a phase-separated DPPC/DLPC membrane. The image shows gel- and 
fluid-phase domains that are enriched with DPPC and DLPC, respectively, in the DPPC/DLPC (1:2 
molar ratio) membrane. 
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Figure 4.10. PCA of a TOF-SIMS image taken at the same location of the phase-separated 
DPPC/DLPC membrane shown in Figure 4.9. Scores images resulting from PCA of the (A) complete 
peak set, (C) contaminant-free peak set, (E) lipid-related peak set, and (G) lipid-related and 
contaminant-free peak set (refer to Table 4.3). The loadings plots for the (B) complete peak set, (D) 
contaminant-free peak set, (F) lipid-related peak set, and (H) lipid-related and contaminant-free peak 
set show the extent that each peak contributed to the spectral variation captured by the corresponding 
PC. 
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We assess the effectiveness of utilizing these peak sets on another supported 
lipid membrane that contained DPPC/DLPC. Figure 4.9 shows the AFM image that 
was acquired from a DPPC/DLPC membrane prior to TOF-SIMS analysis. Figure  
4.10 shows the PC scores images and loadings plots of the same membrane region 
as shown in Figure 4.9 using the peak sets noted in Table 4.3. Analogous to the PCA 
results of DSPC/DLPC, the best contrast between the DPPC enriched gel-phase 
domains and the DLPC enriched fluid-phase domains was in the complete data set 
PCA analysis (contrast= 1.44), followed by the lipid related (1.31) and the 
contaminant-free peak sets (1.30), and the worst contrast was in the contaminant-
free lipid-related peak set (0.97), in which the domains were revealed only in the PC2 
scores image. 
 
Conclusions 
 In this study, we were able to determine lipid-related ion peaks by comparing 
the spectra of isotopologues with PCA, thus creating the first reported comprehensive 
positive-ion fragment list of these phosphatidylcholine lipid species. Moreover, we 
verified that these hydrocarbon fragments also reflected those produced by more 
physiologically relevant lipids with unsaturated fatty acid tails, as previously 
reported,25 by comparing D70-DSPC with unsaturated lipid species. By using limited 
peak sets for building PCA models from dried lipid films of these phosphatidylcholine 
lipid species, it was determined that using a contaminant-free or a contaminant-free 
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lipid-related peak set created the best model. However, in order to enhance the 
discrimination of these lipid species, we suggest that using only contaminant-free 
lipid-related peak set is ideal for analysis. Finally, we evaluated the effectiveness of 
using limited peak sets for PCA of TOF-SIMS images, where it was determined that 
using the complete peak set gave the greatest quantifiable contrast between the gel- 
and fluid-phase regions of both DSPC/DLPC and DPPC/DLPC phase-separated 
supported lipid membranes. However, by relinquishing < 10% of the image contrast 
in both analyses through the use of the lipid related peak set, one can be more 
certain that PCA is revealing the phase-separated membrane regions based on lipid 
content as opposed to contaminants. These results can be used in further analysis of 
related phase-separated lipid membranes containing unsaturated lipid species. 
Furthermore, by having a comprehensive lipid-related fragment list, one can begin to 
identify the origins of peaks detected in the TOF-SIMS analyses of native cell 
membranes. 
 
Materials and Methods 
Preparation of Thin Film Lipid Samples  
DLPC, DSPC, DOPC and D70-DSPC were purchased in chloroform from 
Avanti Polar Lipids (Alabaster, AL) and used without further purification. 15N-DLPC 
was synthesized as previously reported.29 Thin films of each lipid standard were 
created by spotting a 5 µl droplet of 5 mg/ml lipid solution dissolved in chloroform 
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onto a 5 mm x 5 mm silicon substrate, which was patterned with a chrome grid to 
facilitate sample positioning.29 The samples were then placed under vacuum 
overnight to evaporate the solvent. 
 
Preparation of Phase-Separated Supported Lipid Membranes  
Supported lipid membranes composed of a 1:2 molar ratio of DSPC/DLPC and 
DPPC/DLPC, with 1 mol% of the fluorescent lipid, 1-palmitoyl-2-{12-[(7-nitro-2-1,3-
benzoxadiazol-4-yl)amino]lauroyl}-sn-glycero 3-phosphocholine (NBD-PC, Avanti 
Polar Lipids, Alabaster, AL) for visualization with fluorescence microscopy, were 
formed, flash-frozen, and freeze-dried as previously described.19 Fluorescence 
microscopy (Leica DM6000 B, Q-Imaging EXi Blue Fluorescence Microscope) was 
used to evaluate membrane quality. Samples mosaics, enabling imaging of the same 
sample locations with both AFM and TOF-SIMS, were also made by fluorescence 
microscopy.  
 
AFM Imaging of Phase-Separated Lipid Membranes 
An Asylum MFP-3D™ Stand Alone AFM (Asylum Research, Santa Barbara, 
CA) was used to image the freeze-dried supported lipid membranes in ambient air 
and temperature as previously described.19,27 AFM images were flattened to the 
zeroth-order to remove any erratic tip “hops”, and then second-order plane-fitted in 
both the x- and y-plane.  
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TOF-SIMS Analysis of Lipid Films and Phase-Separated Lipid Membranes 
TOF-SIMS analysis was performed on a PHI Trift-III TOF-SIMS (Physical 
Electronics Incorporated, Chanhassen, MN) using a 197Au+ liquid ion gun operated at 
22 kV. A primary ion beam with 8 nA and 1 nA was used to analyze the lipid films and 
phase-separated lipid membranes, respectively. TOF-SIMS spectra of the lipid films 
were acquired from 100 µm × 100 µm sample regions using bunched mode, and 
were acquired at a minimum of twelve different regions on each pure lipid film. TOF-
SIMS analysis of the phase-separated supported lipid membranes was performed in 
unbunched mode for optimal lateral resolution and to minimize analysis time, as 
previously described in Chapter 4.19  
 
PCA of TOF-SIMS Spectra 
PCA was performed using the PLS Toolbox and the MIA Toolbox (v.5.8.1 and 
v.2.0.1, respectively, Eigenvector Research, Manson, WA), which were run in 
MATLAB (v.7.8.0, MathWorks Inc., Natick, MA). Pure film spectra were unit mass 
binned prior to importing into the PLS toolbox. The data were arranged in a matrix in 
which the different samples formed the rows and the individual mass peaks formed 
the columns. Each peak was normalized to the total intensity of the selected peaks 
and mean-centered. PCA produced PC score plots that show the projection of the 
samples onto the new PCs and loadings plots that show the peaks that contributed to 
each PC. Mass peaks with large positive or negative loadings on a PC have relatively 
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higher intensities in the normalized spectra of samples with positive or negative 
scores, respectively.30 The Fisher ratios were calculated as previously described in 
Chapter 4.15 
The TOF-SIMS images of the phase-separated supported lipid membranes 
were imported into MATLAB using unit mass binning, and were downbinned to 128 
pixels x 128 pixels, as previously described.19 The resulting spectra were normalized 
to the total intensity of the selected peaks and autoscaled. A PC model was created, 
and a score value was calculated for each pixel, which was encoded by a 
pseudocolor scale in the resulting scores image. The loadings of each peak on the 
new PCs were also calculated. Image contrast between the gel- and fluid-phase 
membrane domains within each PC scores image was calculated as previously 
reported.8,19,31  
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Chapter 5.  
QUANTITATIVE ANALYSIS OF HOMOGENOUS BINARY 
MIXTURE SUPPORTED LIPID MEMBRANES BY TOF-SIMS 
AND PARTIAL LEAST SQUARES REGRESSION MODELING 
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Introduction  
Cholesterol is an essential component of the eukaryotic cellular membrane. 
The interaction of cholesterol with sphingolipids and saturated phosphatidylcholine 
lipids is responsible for the formation of liquid-ordered (Lo) domains, which are 
assumed to have the same structural and physical properties as lipid rafts found 
within native cell membranes.1-3 The roles of lipid rafts within cell membranes are 
believed to be vital for many functions, including signaling, transport, and sorting.3-9 
As a result, the use of model membranes to elucidate how the abundance of 
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cholesterol within distinct regions of the membrane influences the lipid membrane 
environment has been an area of considerable research.10-17  
Previously, quantitative analysis has demonstrated that stoichiometeric 
complexes between cholesterol and certain lipid species, namely sphingolipids or 
saturated phosphatidylcholine species, administer the creation of Lo lipid domains.10-
12,18 However, determining the lipid composition within the co-existing phases that are 
present in these membranes remains a challenge.18,19 Frequently, the compositions 
of different lipid phases present within model membranes can be identified only if 
phase diagrams have been established for the lipid mixture being studied.16-18,20,21 
Nuclear magnetic resonance (NMR) has been used to determine the composition of 
different lipid phases and to construct phase diagrams of various lipid mixtures, but 
NMR provides bulk measurements and cannot be used to assess the composition 
within specific regions of the membrane.19,22 Investigations with electron 
paramagnetic resonance (EPR) spectroscopy have been useful in determining 
component miscibility between phases, but these analyses require the use of 
isotopically labeled or biradical lipid species, which increases the cost and complexity 
of sample preparation.18,23-26 Synchrotron X-ray diffraction studies have also proven 
valuable for studying model systems,27,28 and recently were used to determine 
cholesterol distribution within three co-existing lipid phases.13 However, the 
availability of this technique is very limited due to the need for a synchrotron light 
source, and these analyses are too cost prohibitive to be a workhorse method for 
115 
systematically studying the behavior of cholesterol within any of the numerous 
possibilities of ternary lipid mixtures. 
Time-of-flight secondary ion mass spectroscopy (TOF-SIMS), on the other 
hand, is a more ubiquitous, label-free technique that is capable of imaging the spatial 
distribution of molecular species within model membranes.29-33 Quantitative 
measurements performed with TOF-SIMS or other SIMS techniques have been 
achieved on membrane structures,30,34-38 but the limitation of these studies are that 
they are either comparative (i.e. determine relative concentrations between samples), 
or require the use of stable isotope-labeled lipids to determine absolute species 
concentrations. However, the interpretation of TOF-SIMS data using multivariate 
analysis (MVA) is a promising approach for quantifying the concentration of specific 
species within lipid membranes.38-40 
Partial least squares regression (PLSR) is a MVA technique that has recently 
been used with TOF-SIMS for quantifying the composition of binary protein films.39 
PLSR is a multivariate calibration method that attempts to find factors that both 
capture the variance and attain correlation between the TOF-SIMS peaks and the 
predicted variable.41 A detailed discussion of PLSR can be found elsewhere.41-44 
Briefly, PLSR is a process that maximizes the covariance between the independent 
predictor variables, X, and the dependent predicted variables, Y.40,42 In the 
application of PLSR to TOF-SIMS data from lipid membranes, the independent 
predictor variables would be the ion peaks in the spectra, and the dependent 
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predicted variables would be the cholesterol or lipid concentration.  Analogous to 
principal component analysis (PCA), PLSR reduces the data complexity by 
calculating a series of new variables, called latent variables (LVs), which are linear 
combinations of the original variables. The LVs are used to calculate the maximum 
variation between X and Y within the data set, while simultaneously correlating the 
predictor (X) variables to the predicted (Y) variables. Regression coefficients are 
determined from the LVs by multivariate linear regression, which describe how the 
variables contribute to the correlation between X and Y. Because PLSR creates a 
predictive model that can be used as a de facto calibration curve to quantitate the 
content of an unknown sample, it is desirable to use as few LVs as possible to 
generate a model with the lowest possible complexity.41 The SIMPLS algorithm is 
commonly used in commercially available software to calculate the PLSR 
parameters,45 and will be used in this study. 
In this chapter, a TOF-SIMS PLSR model was created to determine the 
concentration of cholesterol within binary homogenous supported lipid membranes 
that contain cholesterol and 1,2-dilauroyl-sn-glycero-3-phosphocholine (DLPC). A 
PLSR model was developed using DLPC/cholesterol samples of known composition 
that maximized the covariance between the TOF-SIMS ion peaks and the cholesterol 
concentration independently measured with enzymatic assays. The accuracy of the 
PLSR model was assessed using the root mean squared error of prediction 
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(RMSEP).46 This work establishes a foundation for using PLSR models developed 
with calibration samples to determine the cholesterol content within lipid membranes. 
 
Results and Discussion 
Development of PLSR model for quantifying cholesterol concentrations in DLPC 
supported lipid membranes 
 Binary lipid mixtures containing DLPC and approximately 0, 5, 10, or 15 mol% 
cholesterol were used to create homogenous supported lipid membranes. This range 
of cholesterol concentrations was selected because phase-separation often does not 
occur at higher cholesterol concentrations,35,47,48 and enabling quantification of the 
mol% cholesterol at distinct locations in phase-separated membranes is the longer-
term goal of this research. Prior to membrane formation, the mol% cholesterol in 
each lipid vesicle solution used for membrane formation was measured using 
commercial enzymatic assays (see Materials and Methods section). The 
homogeneous supported lipid membranes used to create a calibration model were 
determined to contain 0, 5, 12, and 25 mol% cholesterol, respectively. Because a 
bilayer cannot be formed from pure cholesterol, a thin film of pure cholesterol was 
used as the 100 mol% cholesterol sample. 
TOF-SIMS measurements were acquired from each sample. Analysis was 
performed only on the regions of the homogenous supported lipid membranes that 
were free of artifacts, and were uniformly fluorescent. PLSR was performed on the 
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resulting TOF-SIMS data using two peak sets. The first was the contaminant-free 
peak set described in Table 4.3 in Chapter 4, but the ion peak m/z= 147 was included 
because it is a significant cholesterol fragment.49 The second consisted of the lipid-
related and contaminant-free peaks listed in Table 4.3, plus several peaks that were 
previously identified as cholesterol-related.49 Note that this second peak set may omit 
additional, unidentified, cholesterol-related peaks that are present in the spectra of 
Piehowski et al.49 For each model, the number of LVs was chosen by using 
continuous block cross validation to create a PLSR model, and then including the LVs 
that improved the root mean square error of cross validation (RMSECV) by ≥2%.41 
Agreement between the TOF SIMS/PLSR and enzymatic assays of the cholesterol 
concentration within the lipid membrane was quantitatively assessed using the 
RMSEP.46 Figure 5.1 shows the predicted cholesterol concentrations in the 
calibration samples from PLSR performed on all the normalized and mean centered 
ion peaks with m/z from 30 to 200 amu, excluding the potassium (m/z = 39), calcium 
(m/z = 40), hydrocarbon (m/z = 41), chrome (m/z = 52), and PDMS (m/z = 73) peaks. 
The four LVs retained in this PLSR model captured 97.9% of the variance in 
cholesterol concentration (98.3% of the spectral variance). The predicted cholesterol 
concentrations from this model are tabulated in Table 5.1. The PLSR model of the 
complete data set and the enzymatic measurements agreed within 3.6 mol% 
(RMSEP), indicating a satisfactory fit. While the model fit well as a whole, individual 
sample predictions did not fit as well. The 0 mol% cholesterol sample was predicted 
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to contain 3.3 mol% cholesterol, and the standard deviation of this sample is the 
largest relative to the predicated cholesterol content. The membranes containing 
cholesterol did, however, fit better, and were well within the standard deviation of 
their respective predicted values. 
 
Figure 5.1. PLSR model from the TOF-SIMS analysis of DLPC/cholesterol supported lipid 
membranes. PLSR was performed on all the normalized ion peaks with m/z from 30 to 200 amu, 
excluding the potassium (m/z = 39), calcium (m/z = 40), hydrocarbon (m/z = 41), chrome (m/z = 52), 
and PDMS (m/z = 73) contaminant peaks. The included peaks were normalized to the total counts in 
the data set and mean-centered. Four latent variables (LVs) were used for this model (A), and 97.9% 
of the variance was retained in the cholesterol concentration. The loadings plot (B) for first and second 
latent variables (LV1 and LV2, respectively) combined captured 94.6% of the variance within the 
spectra. 
  
Table 5.1. Average predicted cholesterol concentration of each homogenous supported lipid 
membrane containing DLPC/cholesterol for the contaminant-free PLSR model (Figure 5.1). 
 
Enzymatically-
measured mol% 
cholesterol 
Average 
predicted from 
Figure 5.1 (4 
LVs) σ 
0 3.3 3.9 
5 4.9 1.9 
12 11.7 1.6 
25 21.8 3.9 
100 101.0 0.6 
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 The loadings plot in Figure 5.1B shows the mass peaks that maximize the 
covariance with cholesterol concentration. Here, LV1 captures the majority of the 
spectral variance (81.4%), and high yielding lipid headgroup- and tail group-related 
peaks (m/z= 42, 43, 55, 57, 86, etc.) have substantial negative correlations to LV1, 
whereas cholesterol-related fragments (m/z= 95, 109, and 147) have less substantial 
positive correlations with LV1. LV2, on the other hand, captures the variance 
between carbonyl-containing fragments (C2H2O+, m/z= 42; C2H5O+, m/z= 45; C3H8O+, 
m/z= 58), which negatively correlate with LV2, and hydrocarbons not containing 
oxygen (C3H7+, m/z= 43; C4H7+, m/z= 55, C5H12N+, m/z= 86, etc.), which positively 
correlates with LV2. 
 
Figure 5.2. PLSR model from the TOF-SIMS analysis of DLPC/cholesterol supported lipid 
membranes. PLSR was performed on only the lipid-related peaks from m/z 30 to 200 listed in Tables 
4.1 and 4.2, and the previously reported cholesterol fragments (m/z= 95, 109, 147, and 161).49 The 
included peaks were normalized to the total counts in the data set and mean-centered. Three LVs 
were used for this model (A), and 96.1% of the variance was retained in the cholesterol concentration. 
The loadings plot (B) for LV1 and LV2 combined captured 93.4% of the variance within the spectra.  
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Table 5.2. Average predicted cholesterol concentration of each homogenous supported lipid 
membrane containing DLPC/cholesterol for the lipid- and cholesterol-related PLSR model (Figure 5.2). 
Enzymatically-
measured mol% 
cholesterol 
Predicted from 
Figure 5.2 (4 
LVs) σ 
0 5.2 4.1 
5 3.7 3.3 
12 11.8 4.4 
25 21.3 4.3 
100 100.0 0.9 
 
Figure 5.2 shows the predicted cholesterol concentrations in the calibration 
samples from PLSR of only the lipid-related peaks from m/z 30 to 200 listed in Tables 
4.1 and 4.2, and the previously reported cholesterol fragments (m/z= 95, 109, 147, 
and 161).49 Only three LVs were retained in this model, which is one less than that 
utilized in the PLSR model of the contaminant-free data set. Perhaps fewer LVs are 
needed for this model due to the reduced peak set. This PLSR model captured 
slightly less of the variance in cholesterol concentration (96.1%), as well as in the 
spectral variance (96.2%), than the contaminant-free model. The predicted 
cholesterol concentrations from this model are tabulated in Table 5.2. These 
predicted values were slightly less accurate than in the contaminant-free model. The 
membrane containing no cholesterol was predicted to have a greater cholesterol 
concentration than the 5 mol% cholesterol membrane. The other samples containing 
higher cholesterol concentrations did fit somewhat better than those containing less 
cholesterol, but the standard deviations of the predicted values were all greater than 
those of the contaminant-free model. Moreover, the PLSR model of this lipid- and 
cholesterol-related peak set and the enzymatic measurements agreed within 4.9 
122 
mol% (RMSEP), indicating that this model had a less satisfactory fit than the 
contaminant-free model.  
Figure 5.2B shows the loadings plot for the lipid- and cholesterol-related PLSR 
model. Here, LV1 captures 82.9% of the spectral variance. Analogous to the 
contaminant-free model, high yielding lipid headgroup- and tail group-related peaks 
negatively correlate to LV1, and cholesterol-related fragments positively correlate 
with LV1. In addition, LV2 captures the variance between carbonyl-containing 
fragments, which in this model positively correlate with LV2, and other hydrocarbons 
not containing oxygen, which negatively correlate with LV2.  
 
Conclusions 
Quantifying the mol% cholesterol within supported lipid membranes using 
TOF-SIMS/PLSR is greatly influenced by the selection of mass peaks included in the 
data set. Better agreement between the mol% cholesterol measured with enzymatic 
assays and TOF-SIMS/PLSR was obtained from the contaminant-free peak set. 
However, use of only the identified lipid- and cholesterol-related peaks reduces the 
number of LVs needed to fit the data, consequently decreasing the complexity of the 
model. Because only four cholesterol-related peaks were included in the restricted 
data set, the performance of the PLSR model constructed using the lipid- and 
cholesterol-related peak set is expected to improve if a more complete cholesterol-
related peak set were available.  
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These results demonstrate that the cholesterol concentration within lipid 
membranes can be quantified by creating PLSR calibration models using 
homogeneous lipid membranes that systematically vary in mol% cholesterol. By 
creating a separate PLSR model for cholesterol-lipid mixtures, in which the lipid 
component forms either an ordered or disordered phase, the cholesterol 
concentration in individual lipid domains within phase-separated lipid membranes 
might be determined. Additional studies on PLSR calibration models for lipid 
membranes may permit extending this calibration methodology to quantifying the 
mol% of specific lipid species within small regions of model membranes. Such 
capabilities would enable the construction of phase diagrams with tie lines that reveal 
the distribution of cholesterol within each lipid phase, and could provide a better 
understanding of how cholesterol-lipid interactions influence membrane organization. 
 
Materials and Methods 
Materials  
The chrome-patterned, oxidized silicon substrates (9-nm-thick oxide layer) 
were prepared as previously described.37 The lipids 1-palmitoyl-2-{12-[(7-nitro-2-1,3-
benzoxadiazol-4-yl)amino]lauroyl}-sn-glycero-3-phosphocholine (NBD-PC), DLPC, 
and cholesterol were purchased from Avanti Polar Lipids, Inc (Alabaster, AL). The 
cholesterol and phospholipid concentrations in the vesicle solutions were measured 
with the Amplex® Red Cholesterol Assay Kit and the Amplex® Red Phospholipase D 
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Assay Kit, respectively, from Molecular Probes (Eugene, OR). Millipore (18 mΩ) 
water was used in all experiments.  
 
Preparation of a pure cholesterol thin film  
A thin cholesterol film was created by spotting a small droplet of cholesterol 
dissolved in chloroform onto a 5 mm x 5 mm silicon substrate that was patterned with 
a chrome grid to facilitate sample positioning.37 The sample was subjected to vacuum 
for a minimum of 3 h to evaporate the solvent. 
 
Preparation of homogenous supported lipid membranes  
Homogenous supported lipid membranes were made as discussed 
elsewhere.35,37 Briefly, small unilamellar vesicles were created with a varying 
cholesterol molar concentration and DLPC. The actual cholesterol concentrations in 
the final vesicle solutions were measured with enzymatic assays (see section 
below).35 A small amount (1 mol%) of the fluorescent lipid, NBD-PC, was added to 
the mixture to allow for the evaluation of membrane formation and integrity using 
fluorescence microscopy. These components were dissolved in chloroform, dried 
under nitrogen, and placed under vacuum to remove residual chloroform. The lipid 
film was resuspended in room temperature water to a final lipid concentration of 0.5 
mg/mL.  The lipid solution was then vortexed until the entire lipid film was in solution. 
The solution was transferred to a plastic tube, and sonicated using a tip sonicator 
125 
(Branson Tip Sonifier Model 250, Branson Ultrasonics, Danbury CT) for 30 s intervals 
until the solution became transparent. The small unilamellar vesicle solution was 
filtered, and 2.5 mL of the filtered vesicle solution was added to a polystyrene culture 
dish containing multiple chrome-patterned, oxidized silicon substrates submerged in 
2.5 mL water. The culture dish was covered, incubated at room temperature for 30 
min to allow for bilayer formation, and then was transferred into a room temperature 
water bath to remove vesicles adhered onto the bilayer. To prepare the lipid 
membranes for the ultrahigh vacuum environment of the SIMS, samples were flash-
frozen in liquid ethane and freeze-dried as previously described.36,37,50 To evaluate 
sample quality, fluorescence imaging was performed on a Leica DM6000 B upright 
fluorescence microscope equipped with a fluorescence filter cube (GFP, Leica) that 
matches the excitation and emission spectra for NBD-PC. 
 
Measurement of mol% cholesterol  
The moles of cholesterol and phosphatidylcholine (PC) in each vesicle solution 
were measured using the Amplex® Red Cholesterol Assay Kit and the Amplex® Red 
Phospholipase D Assay Kit, respectively. The assays were performed in 96-well 
plates purchased from Costar® (Corning, NY), and the fluorescence intensity was 
read using a Synergy HT Multi-Mode Microplate Reader Model SIAFRT (Biotek® 
Instruments, Inc., Winooski, VT). Cholesterol and PC standards were used to create 
the calibration curves. Eight replicates were performed on each vesicle and standard 
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solution. The µmole of cholesterol and PC measured in each small unilamellar 
vesicle solution was used to calculate the mol% of cholesterol. The mol% cholesterol 
in the supported lipid membranes is assumed to be the same as the cholesterol 
content in the vesicle solution used for bilayer formation. 
 
TOF-SIMS analysis 
The freeze-dried homogenous supported lipid membranes were analyzed 
using a PHI Trift-III TOF-SIMS (Physical Electronics Incorporated, Chanhassen, MN). 
A 197Au+ primary ion beam operated at 22 kV with an 8 nA current was used to 
analyze all membrane samples. TOF-SIMS images were acquired over 50 µm × 50 
µm (256 pixels x 256 pixels) sample regions using unbunched mode, for optimal 
lateral resolution and to reduce acquisition time. Careful consideration was taken to 
ensure the chrome grid was never within the analysis region. Spectra were obtained 
with a mass range of 0.1 to 800 amu. TOF-SIMS spectra were acquired over enough 
regions to incorporate at least ten membrane locations of each cholesterol 
concentration used for modeling with PLSR analysis. Analysis times varied to keep a 
constant primary ion dose of 3.3 × 1013 ions/cm2 for all cell samples.  
 
PLSR modeling of TOF-SIMS spectra  
PLSR was performed using the PLS Toolbox (v.6.0.1, Eigenvector Research, 
Manson, WA), which was run in MATLAB (v.7.8.0, MathWorks Inc., Natick, MA).  Unit 
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mass binning was applied to each spectrum acquired from each homogenous 
supported lipid membrane sample. Each mass spectrum of the lipid/cholesterol 
samples was normalized to the total intensity of the selected peaks and mean-
centered. For each model, the number of LVs was chosen by using continuous block 
cross validation to create a PLSR model, and then including the LVs that improved 
the root mean square error of cross validation (RMSECV) by ≥2% (Figure 5.3). 
 
Figure 5.3. RMSECVs plots for the contaminant-free peak set (A) and the lipid- and cholesterol-
related peak set (B) PLSR models. 
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Calculation of RMSEP 
The RMSEP was calculated as previously described,46 using the following 
equation 1: 
 
where yi and ŷi are the reference and predicted value for the ith test sample, 
respectively, of the n test samples. 
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Chapter 6.  
EVALUATING CELLULAR MEMBRANE COMPOSITION 
WITH TOF-SIMS AND MULTIVARIATE ANALYSIS  
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Introduction  
The proteins, lipids, and glycans on the surface of the cell are often 
characteristic of cell type, (i.e., kidney cells and neurons), degree of maturation (i.e., 
stem cells versus differentiated cells), and disease state.1-7 Consequently, tools to 
evaluate the surface composition of individual cells may enable classifying cell type 
according to disease or development, and identifying the changes that occur during 
these processes. Such tools may be especially beneficial to the area of tissue 
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engineering. For example, the ability to detect cell type-specific differences in cell 
surface composition could provide insight into the cell-fate decisions made by stem 
cells, and how the extracellular environment influences this developmental process.8-
13 This information could facilitate the design of the bioscaffolds used in tissue 
regeneration.14-16 In addition, a method to characterize the binding of certain vascular 
endothelial growth factors (VEGFs) to human endothelial cells (ECs) and the 
resulting changes in the cell surface composition17-19 can lead to delineation of the 
regenerative pathways for creating blood vessels, and potentially enable external 
promotion of blood vessel formation.18  
Conventional methods to analyze cell surface composition such as flow 
cytometry and immunoassays require the use of fluorescently labeled antibodies.20-24 
The use of affinity labels to identify cell type, however, requires a priori knowledge of 
which cell surface components are characteristic of cell type.25,26 Consequently, a 
label-free approach with the ability to simultaneously identify multiple components 
within the cell membrane is highly desirable. 
Over the last decade, time-of-flight secondary ion mass spectrometry (TOF-
SIMS) has been applied to analyzing the distinct amino acids, short peptide 
sequences, and lipids present within cellular membranes without the need for 
labels.6,27-32 TOF-SIMS is particularly well-suited for analyzing the membrane 
composition of single cells because secondary ion ejection, and consequently, 
detection, occurs predominately in the outer two monolayers at the sample surface, 
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minimizing any signal contributions of intracellular molecules.33 However, the primary 
ion beam often induces extensive fragmentation of the surface molecules, 
necessitating identification of many biological molecules according to secondary ions 
with m/z< 200.29,33-37 This fragmentation complicates identifying the membrane 
proteins, glycans, and/or lipids that are characteristic of a specific cell type, as their 
low mass (m/z< 200) molecular fragments often correspond to building blocks (i.e., 
amino acids, monosaccharides, and lipid headgroups) that are common to multiple 
biomolecules.  
 Multivariate analysis techniques (MVA) are well-suited for identifying sample-
specific correlations in common mass peaks. Principal component analysis (PCA), an 
unsupervised pattern recognition technique, is perhaps the most popular of such 
post-sampling MVA methods. The capability of PCA to discriminate between samples 
of differing biomolecular composition is based upon the identification of characteristic 
linear combinations of mass peaks that are common to multiple samples. PCA has 
been used to differentiate the TOF-SIMS spectra from a variety of different 
biomolecules.6,27,28,38-42 In addition, PCA has been used to discriminate between 
different spores, cancer cell lines, and tissues according to variations in their 
chemical composition.4-7 However, supervised MVA techniques, which require a set 
of known samples that are employed for model development, may be better suited for 
classifying unknown specimens.43 Partial least squares discriminate analysis (PLS-
DA) is one such supervised MVA method, which attempts to find factors that 
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maximize the covariance between the X variables (e.g. ion peaks in a TOF-SIMS 
spectrum) and the Y variables (e.g. cell types), and can be used to identity unknown 
samples.44 PLS-DA reduces the data complexity, analogous to PCA, by calculating a 
series of new variables called latent variables (LVs) that are linear combinations of 
the original variables. The LVs are used to calculate the maximum variation between 
the X and Y variables and simultaneously achieve correlation within the data set.43, 44 
This chapter will describe the use of MVA methods for TOF-SIMS analysis of 
preserved cell samples to discriminate the cells according to the composition of their 
surface membrane. The first experiments described here were performed in 
collaboration with the Harley research group. PLS-DA was used to distinguish and 
classify two different cell types, HL-1 and MC3T3 cells. HL-1 cells are similar to 
cardiomyocytes,45 and serve as a model cellular system for proof-of-concept 
experiments with the long-term goal of determining how cardiac stem cells 
differentiate as a function of the ECM microstructure. The MC3T3 cells, which are 
mouse clonal osteogenic cells, were used in this proof-of-concept experiment 
because they are significantly different in morphology and cell membrane protein 
composition from HL-1 cells, and are expected to be differentiable by PLS-DA of the 
TOF-SIMS spectra. The second set of experiments discussed here were performed 
in conjunction with the Kong research group with the goal of determining whether 
label-free VEGF 165 bound to the surface of human ECs can be detected. 
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Results and Discussion 
Differentiating cell types 
 TOF-SIMS was used to analyze HL-1 and MC3T3 cell samples cultured on 
silicon substrates in standard growth medium. The mass spectra of six individual 
cells per cell type were extracted from regions within the TOF-SIMS image. The mass 
spectra were unit-massed binned from m/z 30 to 200 amu and normalized to the total 
ion counts of the selected peaks within each spectrum, and mean centered. A PLS-
DA model was created from the known classes of cells (either HL-1 or MC3T3), and 
used to predict the type of two test cells. In each model, the Y variable is set to either 
1 or 0 to indicate whether or not the samples belong to a class (the class being the 
cell type for that model). Because unknown samples will not always be predicted to 
exactly 1 or 0, a threshold must be set, most commonly 0.5, to decide within 
confidence whether or not a sample belongs to a class.44   
The first PLS model was constructed using the normalized, mean centered ion 
peaks with m/z from 30 to 200, excluding the contaminants m/z 39 (K+), 40 (Ca+), 41 
(hydrocarbon), and 73 (PDMS),46 and can be seen in Figure 6.1. Note that although 
peak m/z 147 was previously identified as the PDMS contaminant, it was retained in 
this data set because this peak is also cholesterol-related.47 The resulting model 
contained three LVs (based on RMSECV, see chapter 5) that captured 90.1% of the 
spectral variance. In the HL-1 model (Figure 6.1A), the HL-1 test cell was correctly 
predicted to be a HL-1 cell (predictor = 0.71) whereas the MC3T3 test cell was not 
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predicted to be a HL-1 cell (predictor = 0.09). The MC3T3 model (Figure 6.1B) 
predicted the HL-1 test cell was not a MC3T3 cell (predictor = 0.29), and the MC3T3 
test cell was correctly identified as a MC3T3 cell (predictor = 0.91). 
 
Figure 6.1. PLS-DA classification of HL-1 and MC3T3 cell types from TOF-SIMS spectra of individual 
cells. PLS-DA was performed on all the normalized ion peaks with m/z from 30 to 200 amu, excluding 
the potassium (m/z = 39), calcium (m/z = 40), hydrocarbon (m/z = 41), chrome (m/z = 52), and PDMS 
(m/z = 73) contaminant peaks. The included peaks were normalized to the total counts in the data set 
and mean-centered. Three latent variables (LVs) were used for this model, capturing 84.6% of the 
spectral variance. The test cells were projected onto the class predicting models for the HL-1 and 
MC3T3 cells, (A) and (B), respectively. The loadings plot for the first two LVs can be seen in (C). 
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Table 6.1. Positive-ion peaks of selected amino acids (taken from Ref 27 with permission).  
 
Mass Species Amino Acid abbr. 
30 CH4N glycine Gly 
43 CH3N2 arginine Arg 
44 C2H6N alanine/cysteine Ala/Cys 
55 C3H3O tyrosine Tyr 
57 C3H7N lysine Lys 
58 C2H4NO glycine Gly 
59 CH5N3 arginine Arg 
60 C2H6NO L-serine Ser 
61 C2H5S methionine Met 
68 C4H6N proline Pro 
69 C4H5O threonine Thr 
70 C3H4NO asparagine Asn 
70 C4H8N arginine/leucine/proline Arg/Leu/Pro 
71 C3H3O2 L-serine Ser 
72 C3H6NO glycine Gly 
72 C4H10N valine Val 
73 C2H7N3 arginine Arg 
74 C3H8NO threonine Thr 
76 C2H6NS cysteine Cys 
81 C4H5N2 histidine His 
82 C4H6N2 histidine His 
83 C5H7O valine Val 
84 C4H6NO glutamine Glu 
84 C5H10N lysine Lys 
85 C3H5N2O glycine Gly 
86 C5H12N leucine/isoleucine Leu/Ile 
87 C3H7N2O asparagine/glycine Asn/Gly 
88 C3H6NO2 asparagine/aspartic acid Asn/Asp 
95 C5H7N2 histidine His 
98 C4H4NO2 asparagine Asn 
100 C4H10N3 arginine Arg 
101 C4H11N3 arginine Arg 
104 C4H10NS methionine Met 
107 C7H7O tyrosine Tyr 
110 C5H8N3 arginine/histidine Arg/His 
113 C4H5N2O2 glycine Gly 
115 C4H7N2O2 glycine Gly 
117 C5H9OS methionine Met 
120 C8H10N phenylalanine Phe 
121 C6H5N2O histidine His 
127 C5H11N4 arginine Arg 
130 C9H8N tryptophan Trp 
132 C9H8O phenylalanine Phe 
136 C8H10NO tyrosine Tyr 
159 C10H11N2 tryptophan Trp 
170 C11H8NO tryptophan Trp 
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The loadings plot of the first two LVs used for PLS-DA (Figure 6.1C) suggests 
that classification is based on the relative abundance of lipids and amino acids 
between cell types. The mass peaks with high loadings on LV1 include m/z= 42, 43, 
55, 58, 86, 81, 95, and 105. Each of these mass peaks is related to fragments 
produced by both amino acids and lipids, and therefore may be indicative of 
variations in either the protein or lipid composition on the surface of the cell. For LV2, 
peaks with m/z= 58, 86, 104, 166, and 184 have negative loadings, whereas peaks 
with m/z= 43, 55, 57, 77, 81, and 91 have positive loadings. Although some of these 
peaks are found in the spectra of amino acids (Table 6.1), all of the peaks with high 
negative loadings on LV2 are related to lipid headgroups (Table 4.1), and all peaks 
with high positive loadings on LV2 are related to lipid tail fragments (Table 4.2). 
Therefore, discrimination on LV2 is more likely due to differences in the lengths of the 
fatty acid tails, and not from differences in the amino acids present on the surface of 
the cell.  
However, the loadings on the LVs do not provide a clear indicator of the 
differences in membrane composition between these cell types, and how these 
differences are weighted in classification of each model. If one desired such 
information, then a MVA method like PCA would be more capable of establishing the 
dissimilarities between samples. Nevertheless, the PLS-DA approach could be used 
as a tool for bioengineering purposes, such as classifying how cardiac stem cells 
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differentiate and the influence of the extracellular environment on these cell-fate 
process.8-13 Moreover, the potential to do this in situ could provide information about 
how the microstructure of the surrounding ECM affects such cell-fate decisions.   
 
Identifying membrane modifications 
 Next, TOF-SIMS/PCA was used in the attempt to detect the binding of VEGF 
165 to the surface of human ECs and the resulting changes in the cell surface 
composition. TOF-SIMS analysis was performed on human ECs that were incubated 
for 10 min in the presence or VEGF 165. For comparison, human ECs that were not 
treated with the VEGF 165 were also analyzed. PCA was performed on the 
normalized, mean centered mass ion peaks with m/z 30 to 200, excluding known 
contaminant ion peaks (Figure 6.2). Some separation between the VEGF-treated 
ECs and control ECs was achieved on PC1, but the 95% confidence ellipses of both 
classes intersect in the score plot (Figure 6.2A). PC2 was ineffective at separating 
the VEGF-treated cells from the untreated cells. This relatively poor separation 
implies that either the 10 min VEGF treatment induced very little change in the 
chemical composition of the cell membrane, or that additional ion peaks resulting 
from the VEGF bound to the surface created insignificant spectral variance. In 
addition, the PC1 scores for the cells treated with VEGF had a relatively narrow 
distribution, whereas the PC1 scores for the control cells had a much larger range, 
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suggesting the issue may be due to experimental procedures, which is discussed in 
the section below. 
Even with the short duration of VEGF treatment, changes in cell membrane 
composition will occur,48,49 therefore measureable differences may be attributed to 
these changes, as well as the VEGF binding. Examination of the loadings plot for 
PC1 (Figure 6.2B), which reveals the peaks responsible for the spectral variation 
existing between the two cell sets, provides further insight into the compositional 
differences between samples. Lipid headgroup-related ion peaks (m/z= 58, 59, 86, 
104, 184, etc., see Table 4.1) have positive PC1 loadings, and are therefore more 
relatively abundant on the VEGF-treated ECs. The peaks that load negatively on 
PC1, and are consequently more prevailing in the control ECs, are likely due to 
amino acids (Tyr, m/z= 55; Lys, m/z= 57; Thr, m/z= 69; Asn/Arg/Leu/Pro, m/z= 70; 
Val, m/z= 83; Gly, m/z= 85; Arg, m/z=110, see Table 6.1), though a few of these 
peaks have also been associated with lipid tail groups (i.e., m/z= 55, 57, 69, 83, and 
85). These loadings suggest that the control ECs have a higher protein to lipid ratio 
on their cell surfaces, which is not intuitive, because the VEGF-treated cells should 
presumably have a greater abundance of proteins on the cell surface due to the 
presence of VEGF, which is another protein, unless the VEGF receptor and attached 
VEGF is internalized. To further investigate whether this discrimination was based on 
differences in the protein and lipid composition at the surface of the cell, or from the 
binding of VEGF to the cell surface, PCA was used to identify the peaks related to 
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VEGF. The peaks that differentiated the TOF-SIMS spectra of a dried film of VEGF 
165 on a fibronectin-modified substrate from a control fibronectin-modified substrate 
(Figure 6.3) were identified with PCA. However, PC1 and PC2 were not able to 
differentiate, within confidence the VEGF/fibronectin film from the pure fibronectin film 
(Figure 6.3A). This poor separation suggests that either VEGF and fibronectin are too 
similar in amino acid composition to differentiate their spectra, or there is not enough 
VEGF in the VEGF/fibronectin film to produce a detectable spectral difference. 
Nonetheless, the loadings plot (Figure 6.3B) shows that ion peaks related to 
hydrocarbon chains groups (C3H7+, m/z= 43; C4H7+, m/z= 55; C5H7+, m/z= 67; C5H9+, 
 
Figure 6.2. Scores and loadings plots from PCA of the TOF-SIMS positive-ion spectra of individual 
human endothelial cells (ECs) and vascular endothelial growth factor (VEGF) modified ECs. (A) The 
scores plot on PC1 and PC2 differentiates the cells, and (B) the loadings plot illustrates the positive 
ion mass peaks that contribute to the variation captured by each within PC1 and PC2. PCA was 
performed on all the normalized ion peaks with m/z from 30 to 200 amu, excluding the potassium (m/z 
= 39), calcium (m/z = 40), hydrocarbon (m/z = 41), and PDMS (m/z = 73) contaminant peaks. The 
included peaks were normalized to the total counts in the data set and mean-centered.  
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Figure 6.3. Scores and loadings plots from PCA of the TOF-SIMS positive-ion spectra of VEFG dried 
film and the fibronectin-coated substrate. (A) The scores plots on PC1 and PC2 differentiate the VEGF 
from the control substrate, and (B) the loadings plots illustrate the positive ion mass peaks that 
contribute to the variation captured within PC1 and PC2. PCA was performed on all the normalized ion 
peaks with m/z from 30 to 200 amu, excluding the potassium (m/z = 39), calcium (m/z = 40), 
hydrocarbon (m/z = 41), and PDMS (m/z = 73) contaminant peaks. The included peaks were 
normalized to the total counts in the data set and mean-centered.  
 
m/z= 69; C5H11+, m/z= 71; C6H9+, m/z= 83; and C6H11+, m/z= 85) most positively 
correlate with the PC1, and thus the VEGF/fibronectin film, whereas hydrocarbon ion 
peaks relating to amino acids (Asn/Arg/Leu/Pro, m/z= 70; Gly/Val, m/z= 72; Glu/Lys, 
m/z= 84; Lue/Ili, m/z= 84; Phe, m/z= 120, see Table 6.1) most negatively correlate 
with PC1, and thus the pure fibronectin film. Comparison of the loadings plots in 
Figures 6.2B and 6.3B indicates there are no significant fragments that are shared 
between the loadings that correlate to the VEGF/fibronectin samples and the VEGF-
treated cells. Therefore, separation between the control cells and VEGF-treated cells 
(Figure 6.2) may not be related to the presence of the VEGF, but instead to 
unidentified changes in cell membrane composition. Further optimization of this 
analysis would be required to definitively establish the basis of the PCA separation, 
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which could be addressed by troubleshooting the issues discussed in the next 
section. If achievable, then this could be a valuable tool for determining the influence 
of the VEGF on the proliferation of ECs, and would be useful in bioengineering the 
external promotion of blood vessel formation.  
 
Challenges of TOF-SIMS/MVA for cell analysis 
 Extraction of mass spectra from the largest possible area of the cellʼs surface 
within the TOF-SIMS image is desirable in order to ensure sufficient ion counts for 
the purpose of statistical analysis. Previously, cells have been identified within TOF-
SIMS images by localized increases in ion peaks related to potassium (m/z= 39) and 
phosphocholine (m/z= 184) and a decrease in the sodium ion peak (m/z= 23).50-52 
However, identifying the cell body was a challenge in both of the studies described in 
this chapter because there was no appreciable contrast between cell and substrate in 
these ion images. Consequently, the spectra extracted from the regions of interest 
may be too small to have sufficient ion counts, or may include small areas of the 
substrate, resulting in the variations seen in the data presented above.  
 An example of a TOF-SIMS image of HL-1 cells seeded and preserved on a 
polylysine-coated substrate can be seen in Figure 6.4. The cells are somewhat 
discernable within the total ion image and the total counts of the phosphocholine-
related peaks, m/z= 86 and 184 (Figure 6.4A-C, respectively). However, this contrast 
is due to sample topography, and once the phosphocholine related peaks are 
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normalized to the total ion count no contrast is detectable within the individual ion 
images. As a result, it is difficult to verify by this method that the contrast from 
topography is due to the cell bodies. PCA was performed on these TOF-SIMS 
images in an attempt to separate the cells from the substrate (Figure 6.5). However, 
PCA can discriminate only between the normal areas and the areas of image 
shadowing, which arise when non-uniform current density of the primary ion beam is 
created from surface topography.53 Even by taking steps such as pixel downbinning 
or removing these areas from the image, and performing PCA on the remaining 
portions, discrimination between the cells and the substrates was not achievable 
(images not shown here).  
 
Figure 6.4. TOF-SIMS ion images of HL-1 cells seeded and preserved on a polylysine coated Si 
substrate. The total ion image (A) and the total ion counts for m/z= 86 and 184 (B and C, respectively), 
which are both lipid headgroup related fragments. The normalized ion counts for m/z= 86 and 184 (E 
and F, respectively). The white light image (D) of the approximate region of the TOF-SIMS analysis. 
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Figure 6.5. PCA of the TOF-SIMS positive-ion image in Figure 6.5. (A) PCA was performed on all the 
normalized ion peaks with m/z from 30 to 200 amu, excluding the PDMS contaminant ion peaks (m/z= 
73 and 147) and the non-specific contaminant peak, m/z= 41. (B) PCA was performed on only the 
normalized lipid related ion peaks from 30 to 200 amu (see Tables 4.1 and 4.2), excluding the ion 
peaks of known contaminants (m/z = 40, 41, and 73). The included peaks were normalized to the total 
counts in the data set and autoscaled prior to PCA.  
 
 
Figure 6.6. TOF-SIMS ion images of HL-1 cells cultured and preserved on a bare Si substrate. The 
total ion image (A) and the total ion counts for m/z= 86 and 184 (B and C, respectively), which are 
both lipid headgroup related fragments. The normalized ion counts for m/z= 86 and 184 (E and F, 
respectively). The white light image (D) of the approximate region of the TOF-SIMS analysis. 
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We hypothesized that the uniform phosphocholine ion counts observed on 
substrate was caused by the adherence of free lipids in the medium or material left 
on the substrate after cell migration to the ECM coating (polylysine in the HL-1 cells 
and fibronectin in the ECs experiments). To test this hypothesis, cells were cultured 
on bare silicon substrates that were not coated with polylysine prior to cell seeding.50 
However, contrast was only visible in the total ion image and the total counts of the 
phosphocholine related peaks (Figure 6.6A-C, respectively), and not in the 
normalized individual ion images (Figure 6.6E and F). Investigations using a different 
cell preservation protocol,50 or methods of further extracting the topographical 
artifacts in the TOF-SIMS images54 may resolve this issue and improve the MVA 
analysis of these cell samples. However, due to the successful classification of the 
cell types, the issues with the ECs experiments may be due samples and not the 
analysis.  
 
Conclusions 
 In this chapter, we successfully classified two cell types based on differences 
in cell membrane composition, HL-1 and MC3T3 cells, by capturing the variance 
within the TOF-SIMS spectra and correlating it to known cell samples using PLS-DA. 
This method has significant implications for determining how the ECM microstructure 
can influence cell-fate decisions of cardiac stem cells. For example, this can be used 
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as an in situ technique for determining how these discussions are affected by 
collagen pore sizes and microstructure.  
We also were somewhat successful in differentiating untreated ECs from 
those treated with VEGF 165 for 10 min using PCA. However, the results were 
somewhat unexpected in that there was a relatively greater abundance of protein 
related fragments in the control ECs than in the VEGF-treated cells. Moreover, the 
determination of VEGF related fragments, by comparison to a control sample, was 
inconclusive, and it did not attain ion peaks loadings similar to that being 
differentiated in the PCA of VEGF-treated cells and control cells. Further analyses 
are required to definitely establish the differences between untreated and treated 
cells, the origin of these differences, and whether the binding of the VEGF can be 
detected.  
 
Materials and Methods 
Preparation of HL-1 and  MC3T3 cells 
Silicon chips were sonicated for 15 min in acetone and then autoclaved. After 
passaging, the cell pellet was resuspended in a predetermined amount of complete 
media to obtain a solution with the desired concentration of cells. Cells were seeded 
at constant volume (20 µL), with a seeding density of 5,000 cells/10µL onto 
polylysine coated/uncoated silicon wafers. The cells were allowed to attach for two 
hours after seeding, after which complete media was added to the culture dish (2 mL 
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media/well of 6 well plate). Cells were cultured for 24 hrs at 37 °C and 5% CO2. HL-1 
cells were cultured in Claycomb media supplemented with 10% FBS, 100 µg/mL 
penicillin/streptomycin, 2 mM L-glutamine, and 0.1 mM norepinephrine. MC3T3-E1 
cells were cultured in Alpha-MEM supplemented with 10% FBS, 100 µg/mL 
penicillin/streptomycin, and 2 mM L-glutamine. Cell preservation was performed at 
room temperature. Silicon chips with adherent cells were removed from cell culture 
and rinsed with PBS (with Ca2+ and Mg2+) and Hendryʼs Phosphate Buffer (HPB). 
Cells were subsequently fixed for 30 min in 4% glutaraldehyde diluted in HPB, then 
rinsed once for 5 min in HPB, and twice for 5 min in triple distilled water. The cells 
were further fixed in 0.4% osmium tetroxide solution for 15 min. The samples were 
rinsed three times for 5-10 min in water and air-dried. 
 
Preparation of VGEF-treated and untreated human ECs 
 Silicon chips were sonicated for 15 min in acetone and then autoclaved. 
The sterile silicon chips were coated with recombinant human fibronectin at a 
concentration of 2 μg/cm2 for 1 hr at 37°C. The chips were washed three times with 
sterile phosphate buffered saline solution. Human umbilical vein endothelial cells 
were seeded on the surface at a concentration of 500cells/mL.  The cells were 
allowed to adhere for 24 hrs.  Subsequently, the cells were exposed to 10 ng/ml of 
VEGF for 10 min.  The cells were fixed in a 10% formalin solution for 1 hr.  The fixed 
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cells were washed with DI water three times over a 24 hr period and then allowed to 
dry overnight at room temperature. 
 
TOF-SIMS analysis 
The preserved cell samples were analyzed using a PHI Trift-III TOF-SIMS 
(Physical Electronics Incorporated, Chanhassen, MN). A 197Au+ primary ion beam 
operated at 22 kV with an 8 nA current was used to analyze all cell samples. TOF-
SIMS images of 256 pixels x 256 pixels were acquired over 100 µm × 100 µm sample 
regions using unbunched mode, for optimal lateral resolution and to reduce 
acquisition time. Spectra were obtained with a mass range of 0.1 to 1000 amu. TOF-
SIMS spectra were acquired from enough regions to incorporate at least six cells of 
each type into all MVA analysis. Analysis times varied to keep a constant primary ion 
dose of 3.0 × 1013 ions/cm2 for all cell samples.  
 
MVA of TOF-SIMS spectra of preserved cellular samples 
 The data files generated from the WinCadence software that operates the 
TOF-SIMS instrument were imported directly into MATLAB (v.7.8.0, MathWorks Inc., 
Natick, MA), and were unit mass binned. Using the MIA Toolbox (v.2.0.1, Eigenvector 
Research, Manson, WA) regions of interests with known cell bodies within the TOF-
SIMS image were identified, and the mass spectra of each cell was individually 
extracted. Once completed, the mass spectra were compiled into an Excel 
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spreadsheet, where each spectrum was normalized to the total ion count from m/z= 
30-200. This data was then imported into the PLS toolbox (v.6.0.1 Eigenvector 
Research, Manson, WA), where the ion peaks were removed as indicated in the 
Results and Discussion section. The TOF-SIMS data was arranged in a matrix such 
that the different samples formed the rows and the individual mass peaks formed the 
columns. Each mass spectrum of an individual cell was normalized to the total 
intensity of the selected peaks and mean-centered, and either PLS-DA or PCA was 
performed on the resulting matrix.  
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Chapter 7.  
CONCLUSIONS AND FUTURE PROSPECTS 
Secondary ion mass spectrometry (SIMS) has been demonstrated as a 
valuable technique for analyzing model and native cellular membranes. By coupling 
high resolution SIMS, on a Cameca NanoSIMS 50, with atomic force microscopy, 
unprecedented information about the phase behavior and microstructure of ternary 
mixture supported lipid membranes containing cholesterol was obtained. This 
investigation determined that gel-phase domains remained present within the phase-
separated membrane, containing two saturated phosphocholine lipid species, until a 
critical cholesterol concentration was reached, and the presence of liquid-ordered 
domains was not detected as previously postulated. Further studies of other ternary 
lipid mixtures using this protocol could offer significant insight into the biophysical 
properties of these model membranes.  
The development and optimization of multivariate analysis (MVA) techniques 
with time-of-flight SIMS (TOF-SIMS) provided a label-free method for membrane 
analysis. By using principal component analysis (PCA), the TOF-SIMS positive-ion 
spectra of four structurally similar phosphocholine lipid species were discriminated by 
the variance in the high-yielding, low mass lipid fragments that were common to all 
four species. PCA was also performed on TOF-SIMS images of phase-separated 
supported lipid membranes containing these structurally similar phosphocholine 
lipids, providing better lateral characterization of these membranes than did the 
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individual ion images. The mass spectra of the domain regions were extracted from 
the membrane images, and projected on to a PCA model of pure lipid films for 
component identification. To further optimize this analysis, PCA was used to identify 
the major ion peaks associated with these lipids by comparing isotopically labeled 
and unlabeled lipids. Once the lipid-related ion peaks were identified and compiled, 
they were used to systematically optimize the PCA discrimination of these 
phosphocholine lipids. The ability to acquire quantitative information about the 
composition of homogenous supported membranes, containing one of these lipid 
species and cholesterol, was achieved by using partial least squares regression 
(PLSR) modeling. These models in essence serve as a calibration curve that can be 
used for determining the cholesterol or specific lipid content of unknown supported 
lipid membranes. This has significant implications as a label-free tool for quantifying 
how cholesterol is distributed within phase-separated supported lipid membranes. 
The chemical composition of native cellular membranes was evaluated by 
coupling TOF-SIMS analysis with post-sampling MVA methods. Different cellular 
types were discriminated and classified based upon the composition of their 
respective cellular membranes using PLS discriminate analysis (PLS-DA). These 
results serve as a proof-of-concept, and this method has significant implications for 
such studies as determining how the extracellular matrix microstructure can influence 
cell-fate decisions of cardiac stem cells. PCA was used to determine cellular 
membrane differences between normal human endothelial cells and cells modified 
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with a vascular endothelial growth factor. However, additional investigations are 
required for determining the ion peaks indicative of the binding of the growth factor to 
the membrane receptors. Further development of this method potentially could be 
used to understand and control the regenerative cellular pathways for creating blood 
vessels. Overall, SIMS is a great tool for direct analysis of local composition within 
model and native cell membranes, and can provide valuable insight into these 
systems. 
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APPENDIX. 
IMAGING MODEL MEMBRANES WITH NON-TRADITIONAL 
ANALYTICAL TECHNIQUES 
 
 
Notes and Acknowledgements  
The material is based upon work funded by a Career Award at the Scientific 
Interface from the Burroughs Wellcome Fund held by Mary L. Kraft. Portions of this 
work were carried out in the Frederick Seitz Materials Research Laboratory Central 
Facilities, Univ. of Illinois, which are partially supported by the U.S. Department of 
Energy under grants DE-FG02-07ER46453 and DE-FG02-07ER46471. 
 
Secondary Electron Microscopy Imaging  
The ability to determine phase-separation within supported lipid membranes 
rapidly, label-free, and with lateral resolution applicable to sensing domain sizes on 
the order of cellular lipid rafts (10s of nm) is highly desirable. Fluorescence 
microscopy can image membranes in real-time, but conventionally is diffraction 
limited (~λ/2).1-4 More exotic techniques, such as fluorescence resonance energy 
transfer, have the ability to achieve more desirable lateral resolutions,4,5 yet these 
methods still require the use of labeled molecules, as do all fluorescence methods. 
Atomic force microscopy (AFM), on the other hand, does not require labels and offers 
exceptional lateral of <2 nm for supported lipid membranes.6 However, due to the 
serial nature of this method, real-time information is limited. 
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Conversely, the ability to measure sample thickness of biologically relevant 
samples has been demonstrated by measuring contrast differences in secondary 
electron microscopy (SEM) images.7-9 In these measurements, variations in the 
secondary electron yield are dependent on layer thickness, electronic structure, and 
the surface work function.9,10 Abrupt changes in the secondary electron yields, 
produced by lipid domains of differing thicknesses, has been detected within phase-
separated membranes containing a 1:1 molar ratio of 1,2-dilauroyl-sn-glycero-3-
phosphocholine (DLPC) and 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC) 
during SIMS analysis (unpublished observations). 
 
Figure A.1. (A) AFM topography image of a DSPC:DLPC (1:1 molar ratio) phase-separated supported 
lipid membrane. The topography image illustrates the height difference between the taller gel-phase 
domains (lighter regions) and the lower fluid-phase domains (darker regions). (B) Secondary electron 
microscope (SEM) image of the same membrane location as the AFM topography image in (A). The 
darker membrane regions in the SEM image have a lower secondary electron yield than the brighter 
membrane locations, which match with the AFM image where the gel-phase domains are thicker than 
the fluid-phase domain regions. AFM analysis was performed in ambient air and temperature using an 
Asylum MFP-3D™ Stand Alone AFM. Measurements were taken with standard tapping 300 kHz AFM 
probes (Tap300Al-G, Budget Sensors, Bulgaria) in AC (tapping) mode, and the topography image was 
flattened to the first order. SEM analysis was performed using a Hitachi S4700 SEM with an 
acceleration voltage of 1 kV.  
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With this in mind, phase-separated membranes containing DLPC:DSPC (1:1 
molar ratio) that were made by vesicle fusion followed by slow-cooling, prepared as 
described elsewhere,11,12 were analyzed using SEM. Preliminary results (Figure A.1) 
confirms that phase separation within DLPC:DSPC membranes produces a 
detectable contrast variation in the SEM images. The contrast is in good agreement 
with the AFM image of the same membrane region (Figure A.1A), in which the darker 
regions in the SEM image (indicative of lower secondary electron yield) match with 
the thicker, densely packed gel-phase domains, and the brighter membrane regions 
correlate with the less densely packed fluid-phase area. The detection of phase 
separation in supported lipid membranes by SEM has not been reported, and it might 
serve as a fast, label-free alternative to evaluating phase separation on the 
nanometer scale.  
 
Atomic Force Microscopy Phase-Contrast Imaging  
Typically, AFM is used to measure topographical height differences resulting 
from differences in lipid packing between membrane phases.6,11,14 These 
measurements are commonly made in contact mode, in which the cantilever tip 
scans the sample in close contact with the surface of the membrane, and the 
deflection of the cantilever, as a function of changing height, is measured. However, 
by imaging membranes in AC mode (commonly known as tapping mode), wherein 
the cantilever is oscillated at a set frequency or amplitude and scans the surface by 
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making intermitted contact, changes in cantilever oscillation can be measured (Fig. 
A.2).13,15,16 This mode of operation is referred to here as AFM phase-contrast (AFM-
PC) imaging, and is capable of providing lateral information about sample 
composition, adhesion, and friction.15,16 
  
 
Figure A.2. Scheme of the AFM phase-contrast (AFM-PC) imaging operation, where the cantilever 
oscillation depends on the topography and the composition of the sample. The phase-shift signal in 
AC-AFM mode only changes with variation in the dissipated energy on the sample surface. The image 
shows two different local regions on the flat substrate (brown): the blue region (B), which is made of a 
different material and protrudes from the substrate, and the yellow region (Y), which is flat and only 
changes in materials properties with respect to the substrate. The blue region appears in the height (h) 
signal (topography), whereas the yellow region does not appear in the height trace. However, both 
regions are clearly distinguished from the substrate by recording and plotting the phase signal (Φ). 
Figure adapted from Ref 13. 
 
Here, AFM-PC was used to image phase-separated supported lipid 
membranes that contained 1:1 DLPC:DSPC and either 0 or 5 mol% cholesterol 
(fabrication as described earlier in the appendix). Phase-contrast differences were 
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observed between the fluid- and gel-phase domains as seen in Fig. A.3. More 
interestingly, in the membrane that contained 5 mol% cholesterol, a phase-contrast 
difference is observed at small membrane patches (100-300 nm) within the fluid-
domains (presumably enriched with DLPC) as seen in Fig. A.4. These patches of 
phase-contrast difference in the fluid phase are most abundant around the domain 
interfaces. Membrane patches that exhibit an AFM-PC shift have been reproducibly 
detected in many different supported membranes of similar compositions. We 
speculate that these areas either vary in cholesterol content or have different lipid 
packing. Unfortunately, complementary information gained from SIMS analyses about 
the lateral composition of these membranes has not been obtainable. 
 
Figure A.3. AC-AFM image of a DSPC:DLPC (1:1 molar ratio) phase-separated supported lipid 
membrane. (A) Topography image that illustrates the height difference between the taller gel-phase 
domains (lighter regions) and the lower fluid-phase domains (darker regions). (B) Phase-contrast 
image of the same membrane location as the topography image in (A). Without knowing the state of 
the cantilevers interactions (which is determined by force-curve analyses), it is not possible to state 
whether positive phase-shift (yellow-tinted regions) are attractive or repulsive tip-surface interactions, 
and vice-versa for the negative phase-shifts (purple-tinted regions). AFM analysis was performed in 
ambient air and temperature using an Asylum MFP-3D™ Stand Alone AFM. Measurements were 
taken with standard tapping 300 kHz AFM probes (Tap300Al-G, Budget Sensors, Bulgaria) in AC 
(tapping) mode, and both the topography and phase-contrast images were flattened to the first order. 
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Figure A.4. AC-AFM image of a DSPC:DLPC (1:1 molar ratio) phase-separated supported lipid 
membrane that contains 5 mol% cholesterol. (A) Topography image that illustrates the height 
difference between the taller gel-phase domains (lighter regions) and the lower fluid-phase domains 
(darker regions). (B) Phase-contrast image of the same membrane location as the topography image 
in (A). As compared to the membrane that does not contain cholesterol (Figure A.3), there are many 
patches of discernable phase-contrast within the fluid-phase domain region. AFM analysis was 
performed as described in Figure A.3. 
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